This is a Validated Antibody Database (VAD) review about human APP, based on 406 published articles (read how Labome selects the articles), using APP antibody in all methods. It is aimed to help Labome visitors find the most suited APP antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
APP synonym: AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN-II; PN2; preA4

Knockout validation
Invitrogen
domestic rabbit polyclonal (CT695)
  • western blot knockout validation; mouse; 1:250; loading ...; fig s1
Invitrogen APP antibody (Invitrogen, 51-2700) was used in western blot knockout validation on mouse samples at 1:250 (fig s1). Aging (Albany NY) (2021) ncbi
Abcam
domestic rabbit monoclonal (Y188)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 1e
  • western blot knockout validation; mouse; loading ...; fig 2
  • immunohistochemistry - free floating section; mouse; loading ...; fig 1d
Abcam APP antibody (Epitomics, ab32136) was used in immunohistochemistry knockout validation on mouse samples (fig 1e), in western blot knockout validation on mouse samples (fig 2) and in immunohistochemistry - free floating section on mouse samples (fig 1d). Front Mol Neurosci (2016) ncbi
BioLegend
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4e
BioLegend APP antibody (Biolegend, 803015) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4e). Ann Neurol (2021) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s6b
BioLegend APP antibody (BioLegend, 800701) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s6b). Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; loading ...; fig 6a
BioLegend APP antibody (BioLegend, SIG-39320) was used in immunohistochemistry on mouse samples (fig 6a). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6c
BioLegend APP antibody (Biolegend, 803002) was used in immunohistochemistry on mouse samples at 1:100 (fig 6c). Protein Cell (2021) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:500; loading ...
BioLegend APP antibody (BioLegend, 803001) was used in western blot on mouse samples at 1:500. Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; rat; loading ...; fig 1c
BioLegend APP antibody (BioLegend, 803001) was used in immunohistochemistry on rat samples (fig 1c). Aging (Albany NY) (2021) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 1a
BioLegend APP antibody (BioLegend, 803015) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 1a). Aging Cell (2021) ncbi
mouse monoclonal (6E10)
  • western blot; rat; 1:1000; loading ...; fig 2b
BioLegend APP antibody (BioLegend, 803001) was used in western blot on rat samples at 1:1000 (fig 2b). Cell Rep (2021) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; African green monkey; 1:200; loading ...; fig 1g
BioLegend APP antibody (Biolegend, 800701) was used in immunohistochemistry - paraffin section on African green monkey samples at 1:200 (fig 1g). Protein Cell (2021) ncbi
mouse monoclonal (6E10)
  • ELISA; mouse
BioLegend APP antibody (Covance, 6E10) was used in ELISA on mouse samples . Alzheimers Res Ther (2021) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 5g
BioLegend APP antibody (BioLegend, 800720) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 5g). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; human; 1:500; loading ...; fig 2a
BioLegend APP antibody (Biolegend, 803001) was used in immunohistochemistry on human samples at 1:500 (fig 2a). Nat Immunol (2021) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; human; loading ...; fig 1a
BioLegend APP antibody (Biolegend, 803002) was used in immunohistochemistry on human samples (fig 1a). Front Aging Neurosci (2021) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; fig 8
BioLegend APP antibody (Biolegend, 803004) was used in immunohistochemistry on mouse samples (fig 8). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 4d
BioLegend APP antibody (BioLegend, 803001) was used in immunohistochemistry on mouse samples at 1:500 (fig 4d). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:1000; loading ...; fig 1h
BioLegend APP antibody (BioLegend, 6E10) was used in western blot on mouse samples at 1:1000 (fig 1h). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; human; 1:1000; loading ...; fig 1a
BioLegend APP antibody (BioLegend, 803015) was used in immunohistochemistry on human samples at 1:1000 (fig 1a). Sci Adv (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:100; loading ...
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry on mouse samples at 1:100. Int J Mol Sci (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:1000; loading ...
BioLegend APP antibody (BioLegend, 803001) was used in immunohistochemistry on mouse samples at 1:1000. Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; 1:500; loading ...; fig s2c, s2d
BioLegend APP antibody (Biolegend, 4G8) was used in immunohistochemistry on mouse samples at 1:500 (fig s2c, s2d). Front Pharmacol (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 8a
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3e, 6b
BioLegend APP antibody (Biolegend, 803001) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8a) and in immunohistochemistry on mouse samples at 1:200 (fig 3e, 6b). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; human; 1:250; loading ...; fig 1b
BioLegend APP antibody (BioLegend, 803002) was used in immunohistochemistry - frozen section on human samples at 1:250 (fig 1b). Acta Neuropathol (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 5c
BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 5c). elife (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; loading ...; fig 1b
BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry on mouse samples (fig 1b). iScience (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 2a
BioLegend APP antibody (Biolegend, 6E10) was used in immunohistochemistry on mouse samples at 1:400 (fig 2a). Oxid Med Cell Longev (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; 1:5000; loading ...; tbl 1
BioLegend APP antibody (BioLegend, 4G8) was used in immunohistochemistry on human samples at 1:5000 (tbl 1). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2a
BioLegend APP antibody (Biolegend, 4G8) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2a). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (6E10)
  • other; rat; fig 1
BioLegend APP antibody (Signet Laboratories, 6E10) was used in other on rat samples (fig 1). Biomolecules (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; human; loading ...; fig 7a
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6a
BioLegend APP antibody (Covance, SIG-39220) was used in immunohistochemistry - paraffin section on human samples (fig 7a) and in immunohistochemistry - paraffin section on mouse samples (fig 6a). Int J Mol Sci (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 4h
BioLegend APP antibody (BioLegend, SIG-39320) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 4h). Aging Cell (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - free floating section; mouse; 1:2000; loading ...; fig 3a
BioLegend APP antibody (BioLegend, 6E10) was used in immunohistochemistry - free floating section on mouse samples at 1:2000 (fig 3a). Mol Ther Nucleic Acids (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; human; 1:2000; loading ...; fig 4a
BioLegend APP antibody (Biolegend, 803002) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 4a). J Neuroinflammation (2020) ncbi
mouse monoclonal (11A50-B10)
  • immunohistochemistry; human; 1:200; loading ...; fig 1b
BioLegend APP antibody (Biolegend, 805401) was used in immunohistochemistry on human samples at 1:200 (fig 1b). Acta Neuropathol (2020) ncbi
mouse monoclonal (M3.2)
  • western blot; rat; 1:1000; loading ...; fig 2b
BioLegend APP antibody (BioLegend, 805701) was used in western blot on rat samples at 1:1000 (fig 2b). elife (2020) ncbi
mouse monoclonal (6E10)
  • western blot; rat; 1:1000; loading ...; fig 2c
BioLegend APP antibody (BioLegend, 803001) was used in western blot on rat samples at 1:1000 (fig 2c). elife (2020) ncbi
mouse monoclonal (C1/6.1)
  • proximity ligation assay; rat; 1:1000; loading ...; fig 2a
BioLegend APP antibody (BioLegend, 802801) was used in proximity ligation assay on rat samples at 1:1000 (fig 2a). BMC Neurosci (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 2a
  • western blot; mouse; 1:2000; loading ...; fig ev4a
BioLegend APP antibody (BioLegend, 803002) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 2a) and in western blot on mouse samples at 1:2000 (fig ev4a). EMBO Rep (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 1a
BioLegend APP antibody (BioLegend, 4G8) was used in immunohistochemistry on mouse samples at 1:1000 (fig 1a). Int J Mol Sci (2020) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:1000; loading ...; fig 3a
BioLegend APP antibody (Biolegend, 6E10) was used in western blot on mouse samples at 1:1000 (fig 3a). Int J Mol Sci (2020) ncbi
mouse monoclonal (6E10)
  • other; mouse; 1:2000; loading ...
BioLegend APP antibody (Covance, 6E10) was used in other on mouse samples at 1:2000. J Neurosci (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; human; 1:2000; loading ...; fig 1
BioLegend APP antibody (Biolegend, 803001) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1). Int J Mol Sci (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig s6e
BioLegend APP antibody (BioLegend, SIG-39220) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig s6e). Nat Commun (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 2c, 2d
  • western blot; mouse; loading ...; fig 2h
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2a, 2b
  • western blot; human; loading ...; fig 2g
BioLegend APP antibody (BioLegend, 803001) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 2c, 2d), in western blot on mouse samples (fig 2h), in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2a, 2b) and in western blot on human samples (fig 2g). Nat Commun (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
BioLegend APP antibody (Covance, SIG-39220) was used in immunohistochemistry - paraffin section on mouse samples (fig 3c). Mol Neurodegener (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:300; loading ...; fig 5a
BioLegend APP antibody (Biolegend, 803001) was used in immunohistochemistry on mouse samples at 1:300 (fig 5a). Nat Commun (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 3s1
  • western blot; mouse; 1:1000; loading ...; fig 6e
BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry on mouse samples at 1:1000 (fig 3s1) and in western blot on mouse samples at 1:1000 (fig 6e). Mol Neurodegener (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 2a
BioLegend APP antibody (BioLegend, 803003) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 2a). Mol Neurodegener (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - free floating section; human; 1:5000; loading ...
BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry - free floating section on human samples at 1:5000. J Neuropathol Exp Neurol (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - free floating section; mouse; 1:2000; loading ...; fig s8g
BioLegend APP antibody (Biolegend (previously Covance), SIG-39220) was used in immunohistochemistry - free floating section on mouse samples at 1:2000 (fig s8g). PLoS Biol (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1b
BioLegend APP antibody (Biolegend, 4G8) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1b). Acta Neuropathol (2020) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - frozen section; fruit fly ; 1:500; loading ...; fig 3c
BioLegend APP antibody (BioLegend, SIG-39220) was used in immunohistochemistry - frozen section on fruit fly samples at 1:500 (fig 3c). FEBS Open Bio (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; human; 1:4000; loading ...; fig 2b
BioLegend APP antibody (BioLegend, 803001) was used in immunohistochemistry - paraffin section on human samples at 1:4000 (fig 2b). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; human; 1:4000; loading ...; fig 2b
BioLegend APP antibody (BioLegend, 800702) was used in immunohistochemistry - paraffin section on human samples at 1:4000 (fig 2b). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; human; 1:2000; loading ...; fig 7b
BioLegend APP antibody (Biolegend, 803001) was used in immunohistochemistry - frozen section on human samples at 1:2000 (fig 7b). elife (2019) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; 1:9000; loading ...; tbl 2
BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry on human samples at 1:9000 (tbl 2). Neurology (2020) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:500; loading ...; fig s1
BioLegend APP antibody (BioLegend, 6E10) was used in immunohistochemistry on mouse samples at 1:500 (fig s1). Alzheimers Res Ther (2019) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; loading ...; fig 5g
BioLegend APP antibody (BioLegend, 800712) was used in immunohistochemistry on mouse samples (fig 5g). Cell Rep (2019) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; human; 1:2500; loading ...; fig 4a
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry - paraffin section on human samples at 1:2500 (fig 4a). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; fig 1a
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 1a). Nat Neurosci (2019) ncbi
mouse monoclonal (12F4)
  • immunohistochemistry - free floating section; mouse; loading ...; fig 3g
BioLegend APP antibody (Biolegend, 805501) was used in immunohistochemistry - free floating section on mouse samples (fig 3g). Cell (2019) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; loading ...; fig 3c
BioLegend APP antibody (Covance, SIG-39320) was used in western blot on mouse samples (fig 3c). Sci Adv (2019) ncbi
mouse monoclonal (6E10)
  • immunoprecipitation; human; loading ...; fig 1b
BioLegend APP antibody (Signet Laboratories, 6E10) was used in immunoprecipitation on human samples (fig 1b). J Biol Chem (2019) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:11,000; loading ...; fig 3b
BioLegend APP antibody (BioLegend, SIG-39320) was used in western blot on mouse samples at 1:11,000 (fig 3b). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 4f
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4f). Crit Care (2019) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; 1:500; loading ...; fig 2e
BioLegend APP antibody (BioLegend, SIG-39200) was used in immunohistochemistry on human samples at 1:500 (fig 2e). Sci Adv (2019) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 1b
BioLegend APP antibody (Millipore, SIG-39320) was used in immunohistochemistry on mouse samples at 1:500 (fig 1b). J Comp Neurol (2019) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2f
BioLegend APP antibody (Biolegend, 6E10) was used in immunohistochemistry - frozen section on mouse samples (fig 2f). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:300; loading ...; fig 2d
BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry on mouse samples at 1:300 (fig 2d). Nat Commun (2019) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 3c
BioLegend APP antibody (BioLegend, SIG-39320) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 3c). J Clin Invest (2019) ncbi
mouse monoclonal (C1/6.1)
  • western blot; mouse; 1:1000; loading ...; fig 3h
BioLegend APP antibody (BioLegend, 802801) was used in western blot on mouse samples at 1:1000 (fig 3h). EMBO Mol Med (2019) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:10,000; loading ...; fig 3h
BioLegend APP antibody (BioLegend, SIG-39320-1000) was used in western blot on mouse samples at 1:10,000 (fig 3h). EMBO Mol Med (2019) ncbi
mouse monoclonal (6E10)
  • western blot; human; loading ...; fig s3g
BioLegend APP antibody (BioLegend, 803001) was used in western blot on human samples (fig s3g). Nat Commun (2019) ncbi
mouse monoclonal (M3.2)
  • western blot; mouse; loading ...; fig s2c
BioLegend APP antibody (BioLegend, 805701) was used in western blot on mouse samples (fig s2c). Nat Commun (2019) ncbi
mouse monoclonal (6E10)
  • flow cytometry; mouse; loading ...; fig 3b
  • immunohistochemistry; mouse; loading ...; fig 3b
BioLegend APP antibody (Covance, 6e10) was used in flow cytometry on mouse samples (fig 3b) and in immunohistochemistry on mouse samples (fig 3b). Front Cell Neurosci (2018) ncbi
mouse monoclonal (C1/6.1)
  • western blot; human; 1:1000; loading ...; fig s1b
BioLegend APP antibody (Biolegend, 802801) was used in western blot on human samples at 1:1000 (fig s1b). Science (2018) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2e
BioLegend APP antibody (Covance Research Products Inc, 6E10) was used in immunohistochemistry - frozen section on mouse samples (fig 2e). Neurobiol Aging (2018) ncbi
mouse monoclonal (6E10)
  • western blot; human; loading ...; fig 3a
BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples (fig 3a). Mol Psychiatry (2018) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - free floating section; mouse; loading ...; fig 1a
BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry - free floating section on mouse samples (fig 1a). Aging Cell (2018) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 6c
  • western blot; mouse; 1:1000; loading ...; fig 8b
BioLegend APP antibody (BioLegend, 803001) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6c) and in western blot on mouse samples at 1:1000 (fig 8b). Autophagy (2018) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; fig 3b
BioLegend APP antibody (Covance, 6E10) was used in western blot on mouse samples (fig 3b). Acta Neuropathol Commun (2018) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; ; loading ...; fig 6t
BioLegend APP antibody (BioLegend, SIG-39320-1000) was used in western blot on mouse samples at (fig 6t). J Exp Med (2018) ncbi
mouse monoclonal (C1/6.1)
  • western blot; mouse; 1:1000; loading ...; fig 6t
BioLegend APP antibody (BioLegend, 802801) was used in western blot on mouse samples at 1:1000 (fig 6t). J Exp Med (2018) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:1000; loading ...; fig s1
BioLegend APP antibody (Covance, 6E10) was used in western blot on mouse samples at 1:1000 (fig s1). Nature (2018) ncbi
domestic rabbit polyclonal (Poly8134)
  • western blot; human; loading ...; fig 1r
BioLegend APP antibody (Covance, SIG-39138) was used in western blot on human samples (fig 1r). Nat Med (2018) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:5000; loading ...; fig 1b
BioLegend APP antibody (BioLegend, 803001) was used in western blot on mouse samples at 1:5000 (fig 1b). J Exp Med (2018) ncbi
mouse monoclonal (6E10)
  • immunocytochemistry; mouse; loading ...; fig 3a
BioLegend APP antibody (BioLegend, 803001) was used in immunocytochemistry on mouse samples (fig 3a). J Neuroinflammation (2018) ncbi
mouse monoclonal (11A50-B10)
  • ELISA; mouse; loading ...; fig 3d
BioLegend APP antibody (BioLegend, 805407) was used in ELISA on mouse samples (fig 3d). J Neuroinflammation (2018) ncbi
mouse monoclonal (12F4)
  • ELISA; mouse; loading ...; fig 3d
BioLegend APP antibody (BioLegend, 805507) was used in ELISA on mouse samples (fig 3d). J Neuroinflammation (2018) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 5a
  • western blot; mouse; 1:2000; loading ...; fig 4a
BioLegend APP antibody (Signet, SIG-39330-200) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 5a) and in western blot on mouse samples at 1:2000 (fig 4a). J Exp Med (2018) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; loading ...; fig s6b
BioLegend APP antibody (BioLegend, 803002) was used in immunohistochemistry on mouse samples (fig s6b). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (6E10)
  • western blot; human; loading ...; fig 1a
BioLegend APP antibody (Covance, SIG-39320) was used in western blot on human samples (fig 1a). Cell Mol Life Sci (2018) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; African green monkey; 1:12,000; loading ...; fig 4a
BioLegend APP antibody (BioLegend, SIG-39320) was used in immunohistochemistry - frozen section on African green monkey samples at 1:12,000 (fig 4a). Neurobiol Aging (2018) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:2500; loading ...; fig 5a
BioLegend APP antibody (Covance, SIG-39320) was used in western blot on mouse samples at 1:2500 (fig 5a). Am J Pathol (2018) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; 1:3000; loading ...; fig 1a
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry - frozen section on mouse samples at 1:3000 (fig 1a). EMBO J (2018) ncbi
mouse monoclonal (6E10)
  • western blot; human; fig 2a
BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples (fig 2a). Oncotarget (2017) ncbi
domestic rabbit polyclonal (Poly8134)
  • western blot; human; loading ...; fig 8a
BioLegend APP antibody (Covance, SIG-39138) was used in western blot on human samples (fig 8a). Exp Neurol (2018) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - free floating section; human; loading ...; fig 4d
BioLegend APP antibody (Covance, SIG-39347) was used in immunohistochemistry - free floating section on human samples (fig 4d). Exp Neurol (2018) ncbi
mouse monoclonal (6E10)
  • immunocytochemistry; rat; 1:1000; loading ...; fig 7a
BioLegend APP antibody (BioLegend, 803001) was used in immunocytochemistry on rat samples at 1:1000 (fig 7a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; African green monkey; 1:7500; loading ...; fig 1a
BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry - frozen section on African green monkey samples at 1:7500 (fig 1a). Neurobiol Aging (2017) ncbi
mouse monoclonal (6E10)
  • immunocytochemistry; human; 1:1000; loading ...; fig 6a
  • western blot; human; loading ...; fig s1a
In order to study the involvement of deacetylase HDAC6 in Tau pathology, BioLegend APP antibody (BioLegend, SIG-39320) was used in immunocytochemistry on human samples at 1:1000 (fig 6a) and in western blot on human samples (fig s1a). Cell Rep (2017) ncbi
mouse monoclonal (6E10)
  • immunocytochemistry; mouse; loading ...; fig s5b
BioLegend APP antibody (BioLegend, 803001) was used in immunocytochemistry on mouse samples (fig s5b). PLoS Genet (2017) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; loading ...; fig 4d
BioLegend APP antibody (Covance, 6E10) was used in western blot on mouse samples (fig 4d). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2a
In order to investigate the accumulation of TMEM230 in granulovacuolar degeneration bodies and dystrophic neurites of Alzheimers disease, BioLegend APP antibody (BioLegend, SIG-39320-200) was used in immunohistochemistry - paraffin section on human samples (fig 2a). J Alzheimers Dis (2017) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; loading ...; fig 3c
In order to show that ALOX5 upregulation results in homocysteine-dependent worsening of the Alzheimer's disease phenotype, BioLegend APP antibody (Covance, SIG-39220) was used in immunohistochemistry on mouse samples (fig 3c). Sci Rep (2017) ncbi
mouse monoclonal (4G8)
  • immunocytochemistry; rat; loading ...; fig s4b
BioLegend APP antibody (Covance, SIG39220) was used in immunocytochemistry on rat samples (fig s4b). Front Cell Neurosci (2017) ncbi
mouse monoclonal (6E10)
  • western blot; human; 1:2000; loading ...; fig 4a
BioLegend APP antibody (BioLegend, 6E10) was used in western blot on human samples at 1:2000 (fig 4a). PLoS ONE (2017) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; loading ...; fig 2a
In order to examine tau distribution and release using organotypic brain slice cultures, BioLegend APP antibody (Covance Research Products, SIG-39300-200) was used in western blot on mouse samples (fig 2a). Cell Death Dis (2017) ncbi
mouse monoclonal (12F4)
  • immunohistochemistry - free floating section; mouse; 1:1000; loading ...; fig 5a
  • western blot; mouse; 1:1000
In order to characterize physiological conformations of Abeta and amyloid precursor protein, BioLegend APP antibody (BioLegend, SIG-39142) was used in immunohistochemistry - free floating section on mouse samples at 1:1000 (fig 5a) and in western blot on mouse samples at 1:1000. Nat Commun (2017) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - free floating section; mouse; loading ...; fig 4j
BioLegend APP antibody (Signet Laboratories, SIG-39320) was used in immunohistochemistry - free floating section on mouse samples (fig 4j). Front Neurosci (2017) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; human; 1:1000; loading ...; fig 5a
In order to purify peripheral plasma exosomes and observe exosome diffusion in the hippocampus of an Alzheimer's disease mouse model, BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry on human samples at 1:1000 (fig 5a). Front Aging Neurosci (2017) ncbi
mouse monoclonal (C1/6.1)
  • proximity ligation assay; rat; fig 5D
BioLegend APP antibody (Biolegend, 802801) was used in proximity ligation assay on rat samples (fig 5D). Front Mol Neurosci (2017) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:1000; loading ...; fig 1e
In order to assess the effects of choline using a mouse model of Alzheimer's disease, BioLegend APP antibody (BioLegend, SIG-39320) was used in western blot on mouse samples at 1:1000 (fig 1e). PLoS ONE (2017) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig s2a
BioLegend APP antibody (Covance, SIG-39300) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig s2a). Stem Cell Reports (2017) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 1a
In order to design a quantitative 3D in silico modeling platform allowing for true 3D quantitation of amyloid-beta phagocytosis by mononuclear phagocytes in rodent Alzheimer's Disease models, BioLegend APP antibody (Covance, SIG-39220) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1a). J Vis Exp (2016) ncbi
mouse monoclonal (6E10)
  • immunocytochemistry; human; 1:100; loading ...; fig 5b
BioLegend APP antibody (Biolegends, SIG-39320) was used in immunocytochemistry on human samples at 1:100 (fig 5b). Acta Neuropathol (2017) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; human; 1:2000; loading ...; tbl 1
In order to describe a dichotomy between graft structure and clinical function in a patient dying 16 years following fetal nigral grafting, BioLegend APP antibody (Covance, SIG-39300) was used in immunohistochemistry on human samples at 1:2000 (tbl 1). Ann Neurol (2017) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:1000; loading ...
In order to study the role of the STIM2-regulated TRPC6/Orai2 nSOC channel complex in dendritic mushroom spines in models of Alzheimer's disease, BioLegend APP antibody (Covance, SIG-39300) was used in western blot on mouse samples at 1:1000. J Neurosci (2016) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1d
  • western blot; mouse; 1:1000; loading ...; fig 1f
In order to explore the role of necrostatin-1 in Alzheimer's disease, BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1d) and in western blot on mouse samples at 1:1000 (fig 1f). EMBO Mol Med (2017) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; human; 1:4000; loading ...; fig 6
In order to evaluate chronic traumatic encephalopathy-like changes during routine neuropathology services, BioLegend APP antibody (BioLegend, SIG39220-500) was used in immunohistochemistry - paraffin section on human samples at 1:4000 (fig 6). J Neuropathol Exp Neurol (2016) ncbi
mouse monoclonal (6E10)
  • western blot; human; loading ...; fig 3b
In order to suggest that loss of the Wnt signaling pathway may contribute to Alzheimer's disease pathogenesis, BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples (fig 3b). J Neurochem (2016) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 3
In order to characterize an Alzheimer's disease model that utilizes Octodon degus, BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 3). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; rat; 1:2000; fig 3
In order to characterize an Alzheimer's disease model that utilizes Octodon degus, BioLegend APP antibody (Covance, SIG-39220) was used in immunohistochemistry - paraffin section on rat samples at 1:2000 (fig 3). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; fig 4
BioLegend APP antibody (Covance, 6E10) was used in western blot on mouse samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; 1:100; fig 4d
In order to test if the leptomeningeal arteries derived from patients with cerebral amyloid angiopathy have a distinct endophenotypic profile compared to those from young and elderly controls, BioLegend APP antibody (BioLegend, 800701) was used in immunohistochemistry on human samples at 1:100 (fig 4d). Neuropathol Appl Neurobiol (2017) ncbi
mouse monoclonal (6E10)
  • western blot; human; loading ...; fig 1b
BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples (fig 1b). J Neurosci (2016) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 3b
BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 3b). J Neurosci (2016) ncbi
mouse monoclonal (6E10)
In order to describe the role of miR-132 in amyloid and TAU pathology associated with Alzheimer's disease, BioLegend APP antibody (BioLegend, 803002) was used . EMBO Mol Med (2016) ncbi
domestic rabbit polyclonal (Poly8134)
In order to describe the role of miR-132 in amyloid and TAU pathology associated with Alzheimer's disease, BioLegend APP antibody (Covance BioLegend, 813401) was used . EMBO Mol Med (2016) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - free floating section; human; 1:1000; loading ...; fig 7c
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 7c
  • immunohistochemistry - free floating section; mouse; 1:1000; loading ...; fig 3b
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 3b
  • western blot; mouse; 1:2000; loading ...; fig st7
In order to identify NFE2L2/NRF2 as a regulator of autophagy gene expression and study its role in Alzheimer disease, BioLegend APP antibody (Covance, SIG-39220-200) was used in immunohistochemistry - free floating section on human samples at 1:1000 (fig 7c), in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 7c), in immunohistochemistry - free floating section on mouse samples at 1:1000 (fig 3b), in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 3b) and in western blot on mouse samples at 1:2000 (fig st7). Autophagy (2016) ncbi
mouse monoclonal (6E10)
  • western blot; fruit fly ; 1:10,000; loading ...; fig 1
BioLegend APP antibody (Covance, Sig-39340-200) was used in western blot on fruit fly samples at 1:10,000 (fig 1). Biol Open (2016) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 4
In order to elucidate the pathological conversion of tau facilitated by the neuritic plaque in an Alzheimer's disease mouse model, BioLegend APP antibody (Covance, SIG-39300) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (6E10)
  • western blot; human; 1:2000; fig 2
BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples at 1:2000 (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; human; 1:500; fig 2
In order to study the human brain after blast exposure in post-mortem cases to characterize the interface astroglial scarring, BioLegend APP antibody (Covance, SIG-39220) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2). Lancet Neurol (2016) ncbi
mouse monoclonal (4G8)
  • blocking or activating experiments; human; fig 3
  • immunohistochemistry; human; fig 2
In order to determine protection against microbial infection in mouse and worm models of Alzheimer's disease by the amyloid-beta peptide, BioLegend APP antibody (Covance, 4G8) was used in blocking or activating experiments on human samples (fig 3) and in immunohistochemistry on human samples (fig 2). Sci Transl Med (2016) ncbi
mouse monoclonal (6E10)
  • western blot; human; fig 1
BioLegend APP antibody (covance, SIG39320) was used in western blot on human samples (fig 1). Protein Cell (2016) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; fig s1
BioLegend APP antibody (Covance, SIG-39300) was used in western blot on mouse samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (12F4)
In order to study a novel platform based on the planar frequency mixing magnetic technique that is a magnetic immunoassay, BioLegend APP antibody (Covance, SIG-39144) was used . Biosens Bioelectron (2016) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:100; fig 3
  • western blot; mouse; 1:1000; fig 3
BioLegend APP antibody (covance, SIG-39320-200) was used in immunohistochemistry on mouse samples at 1:100 (fig 3) and in western blot on mouse samples at 1:1000 (fig 3). J Neuroinflammation (2016) ncbi
mouse monoclonal (6E10)
In order to study behavioral deficits without pathological interaction by humanized tau mice with regionalized amyloid, BioLegend APP antibody (BioLegend, 803015) was used . PLoS ONE (2016) ncbi
mouse monoclonal (6E10)
  • western blot; human; fig 2
BioLegend APP antibody (Covance, SIG-39300) was used in western blot on human samples (fig 2). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (6E10)
  • western blot; fruit fly ; fig 1
In order to study the augmentation of AD-related phosphorylation and A-beta42-induced tau toxicity created by stabilization of microtubule-unbound tau via tau phosphorylation at Ser262/356 by Par-1/MARK, BioLegend APP antibody (Covance, 6E10) was used in western blot on fruit fly samples (fig 1). PLoS Genet (2016) ncbi
domestic rabbit polyclonal (Poly8134)
  • western blot; mouse; 1:1000; loading ...; fig 4d
In order to characterize epigenetic changes in 5XFAD mice, BioLegend APP antibody (Covance, SIG-39138-050) was used in western blot on mouse samples at 1:1000 (fig 4d). Aging (Albany NY) (2016) ncbi
mouse monoclonal (4G8)
  • immunoprecipitation; human; 1:500-1:2500; fig 1H
BioLegend APP antibody (Covance, SIG?\39220) was used in immunoprecipitation on human samples at 1:500-1:2500 (fig 1H). EMBO Mol Med (2016) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:5000; loading ...; fig 7a
BioLegend APP antibody (803016, 803016) was used in western blot on mouse samples at 1:5000 (fig 7a). Autophagy (2016) ncbi
mouse monoclonal (6E10)
  • immunoprecipitation; human; fig 4
BioLegend APP antibody (Covance, 6E10) was used in immunoprecipitation on human samples (fig 4). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (4G8)
  • immunoprecipitation; human; fig 4
BioLegend APP antibody (Covance, 4G8) was used in immunoprecipitation on human samples (fig 4). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - free floating section; human; 1:1000; tbl 2
In order to characterize the frontal cortex of wild mountain gorillas (Gorilla beringei beringei) for early Alzheimer's disease-type pathology, BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry - free floating section on human samples at 1:1000 (tbl 2). Neurobiol Aging (2016) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:100; fig 4
  • western blot; mouse; 1:1000; fig 4
In order to assess rescue of Alzheimer's disease in the mouse by improved proteostasis in the secretory pathway, BioLegend APP antibody (Signet, 6E10) was used in immunohistochemistry on mouse samples at 1:100 (fig 4) and in western blot on mouse samples at 1:1000 (fig 4). Brain (2016) ncbi
mouse monoclonal (6E10)
  • western blot; human; 1:1000; tbl 1
  • western blot; mouse; 1:1000; tbl 1
In order to study reduction of hyperphosphorilated Tau by beta-secretase 1's targeting implying autophagy actors in 3xTg-AD mice, BioLegend APP antibody (Signet, 6E10) was used in western blot on human samples at 1:1000 (tbl 1) and in western blot on mouse samples at 1:1000 (tbl 1). Front Cell Neurosci (2015) ncbi
mouse monoclonal (4G8)
BioLegend APP antibody (BioLegend, 800702) was used . J Neurosci (2016) ncbi
mouse monoclonal (6E10)
  • western blot; hamsters; fig 7
In order to identify and characterize a multiprotease complex containing both alpha- and gamma-secretase, BioLegend APP antibody (Covance, 6E10) was used in western blot on hamsters samples (fig 7). J Cell Biol (2015) ncbi
mouse monoclonal (6E10)
  • western blot; fruit fly ; 1:2000; fig 2O
BioLegend APP antibody (Covance, 6E10) was used in western blot on fruit fly samples at 1:2000 (fig 2O). Dis Model Mech (2016) ncbi
mouse monoclonal (4G8)
  • ELISA; mouse; 1:2500; fig 2
  • western blot; mouse; fig 1
In order to assess the impairment in synaptic plasticity and learning due to amyloid-beta dimers in the absence of plaque pathology, BioLegend APP antibody (Covance, 4G8) was used in ELISA on mouse samples at 1:2500 (fig 2) and in western blot on mouse samples (fig 1). Brain (2016) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; fig 2i
  • western blot; mouse; fig 2f
In order to study Alzheimer's-like neurodegeneration by L-methionine by looking at changes in A-beta oligomers, synaptic proteins, Wnt signaling, tau phosphorylation, and behavioral impairment in wild-type mice, BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry on mouse samples (fig 2i) and in western blot on mouse samples (fig 2f). Mol Neurodegener (2015) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; fig 5
In order to characterize the interaction of TRPC6 with APP to inhibit its cleavage by gamma-secretase and reduce A-beta production, BioLegend APP antibody (Signet, SIG-39300) was used in immunohistochemistry on mouse samples (fig 5). Nat Commun (2015) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; fig s5
BioLegend APP antibody (covance, SIG 39320-200) was used in western blot on mouse samples (fig s5). Front Cell Neurosci (2015) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:1500; fig 3
  • western blot; human; 1:1500; fig 3
BioLegend APP antibody (Covance, 6E10) was used in western blot on mouse samples at 1:1500 (fig 3) and in western blot on human samples at 1:1500 (fig 3). Acta Neuropathol Commun (2015) ncbi
domestic rabbit monoclonal (1-11-3)
  • ELISA; human; fig s8
  • ELISA; mouse; fig s8
BioLegend APP antibody (Covance, 1-11-3) was used in ELISA on human samples (fig s8) and in ELISA on mouse samples (fig s8). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; 1:250; fig 5
  • immunohistochemistry; mouse; 1:250; fig 5
BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry on human samples at 1:250 (fig 5) and in immunohistochemistry on mouse samples at 1:250 (fig 5). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:2000; fig 5e
In order to investigate the contribution of TRPM2 to beta-amyloid neuronal toxicity, BioLegend APP antibody (Covance, 6E10) was used in western blot on mouse samples at 1:2000 (fig 5e). J Neurosci (2015) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:500; fig 4
In order to characterize linalool that reverses behavioral and neuropathological impairments in old triple transgenic Alzheimer's mice, BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry on mouse samples at 1:500 (fig 4). Neuropharmacology (2016) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; 1:1000; fig 1
In order to assess microglia phenotypes during chronic neuroinflammation, BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 1). J Neuroinflammation (2015) ncbi
mouse monoclonal (6E10)
  • western blot; human; 1:1000
BioLegend APP antibody (Covance, SIG-39320) was used in western blot on human samples at 1:1000. Brain (2016) ncbi
mouse monoclonal (6E10)
  • ELISA; human; 2 ug/ml; fig 6
In order to investigate the pathophysiology of the hypoperfusion in Alzheimer's disease, BioLegend APP antibody (Covance, 6E10) was used in ELISA on human samples at 2 ug/ml (fig 6). Brain Pathol (2016) ncbi
mouse monoclonal (11A50-B10)
  • ELISA; human; 1 ug/ml; fig 6
In order to investigate the pathophysiology of the hypoperfusion in Alzheimer's disease, BioLegend APP antibody (Covance, 11A50-B10) was used in ELISA on human samples at 1 ug/ml (fig 6). Brain Pathol (2016) ncbi
mouse monoclonal (12F4)
  • ELISA; human; 1 ug/ml; fig 6
In order to investigate the pathophysiology of the hypoperfusion in Alzheimer's disease, BioLegend APP antibody (Covance, 12F4) was used in ELISA on human samples at 1 ug/ml (fig 6). Brain Pathol (2016) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; loading ...; fig 9a
BioLegend APP antibody (Covance, Ab1-16) was used in immunohistochemistry on mouse samples (fig 9a). PLoS ONE (2015) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; loading ...; fig 6a
In order to determine the effects of traumatic brain injury in the presence and absence of beta-amyloid, BioLegend APP antibody (Signet Labs, 6E10) was used in western blot on mouse samples (fig 6a). J Neurotrauma (2016) ncbi
mouse monoclonal (4G8)
  • immunoprecipitation; mouse
BioLegend APP antibody (Covance, 4G8) was used in immunoprecipitation on mouse samples . Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 3
In order to characterize changes that occur during the accumulation of amyloid beta in artery walls, BioLegend APP antibody (Covance, SIG39220) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; human; tbl 1
In order to characterize the neuropathologic evaluation of Alzheimer's disease by multisite assessment of NIA-AA guidelines, BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry on human samples (tbl 1). Alzheimers Dement (2016) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; tbl 1
In order to characterize the neuropathologic evaluation of Alzheimer's disease by multisite assessment of NIA-AA guidelines, BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry on human samples (tbl 1). Alzheimers Dement (2016) ncbi
mouse monoclonal (M3.2)
  • western blot; rat; 1:1000
In order to localize ADAM10 and BACE1 in synaptic vesicles, BioLegend APP antibody (BioLegend, SIG-39155) was used in western blot on rat samples at 1:1000. J Neurochem (2015) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; fig 4
In order to investigate the role of CCAAT/enhancer-binding protein delta in murine models of prion and Alzheimer's disease, BioLegend APP antibody (Covance, SIG-39300) was used in western blot on mouse samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (12F4)
  • western blot; mouse; 1:500; fig 4
BioLegend APP antibody (BioLegend Co, SIG-39142;) was used in western blot on mouse samples at 1:500 (fig 4). Ann Thorac Surg (2015) ncbi
mouse monoclonal (12F4)
  • western blot; mouse; 1:500; fig 4
In order to investigate the link between prion disease and Alzheimer disease, BioLegend APP antibody (BioLegend Co, SIG-39142;) was used in western blot on mouse samples at 1:500 (fig 4). J Neuropathol Exp Neurol (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; 1:100
BioLegend APP antibody (Covance, SIG-39220) was used in immunohistochemistry on mouse samples at 1:100. Mol Neurodegener (2015) ncbi
domestic rabbit polyclonal (Poly8134)
BioLegend APP antibody (BioLegend, 813401) was used . Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (M3.2)
  • immunoprecipitation; mouse; 1:300
  • western blot; mouse; 1:800
BioLegend APP antibody (BioLegend, 805701) was used in immunoprecipitation on mouse samples at 1:300 and in western blot on mouse samples at 1:800. Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (C1/6.1)
  • western blot; mouse; 1:1000
BioLegend APP antibody (BioLegend, 802802) was used in western blot on mouse samples at 1:1000. Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; 1:500
In order to characterize the neuropathological features of dystonias, BioLegend APP antibody (Covance, SIG-39220) was used in immunohistochemistry on human samples at 1:500. Tremor Other Hyperkinet Mov (N Y) (2015) ncbi
mouse monoclonal (6E10)
  • western blot; fruit fly
BioLegend APP antibody (Signet Laboratories, 6E-10) was used in western blot on fruit fly samples . Amyloid (2015) ncbi
mouse monoclonal (4G8)
In order to classify subtypes of amyloid-beta oligomers, BioLegend APP antibody (Covance, SIG-39220) was used . Cell Rep (2015) ncbi
domestic rabbit monoclonal (1-11-3)
In order to classify subtypes of amyloid-beta oligomers, BioLegend APP antibody (Covance, SIG-39169) was used . Cell Rep (2015) ncbi
mouse monoclonal (6E10)
In order to classify subtypes of amyloid-beta oligomers, BioLegend APP antibody (Covance, SIG-39320) was used . Cell Rep (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; loading ...; fig 1f
BioLegend APP antibody (Covance, SIG-39200) was used in immunohistochemistry on mouse samples (fig 1f). PLoS ONE (2015) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - free floating section; mouse; 1:200
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry - free floating section on mouse samples at 1:200. Brain (2015) ncbi
mouse monoclonal (6E10)
  • other; human; 1:100; loading ...; fig 2a
BioLegend APP antibody (Covance, 6E10) was used in other on human samples at 1:100 (fig 2a). J Neurochem (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - frozen section; human
BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry - frozen section on human samples . Nucl Med Biol (2015) ncbi
domestic rabbit monoclonal (1-11-3)
  • western blot; mouse
In order to develop and characterize a novel transgenic mouse model of Abeta toxicity, BioLegend APP antibody (Covance, SIG-39169) was used in western blot on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (LN27)
  • western blot; mouse
In order to develop and characterize a novel transgenic mouse model of Abeta toxicity, BioLegend APP antibody (Covance, SIG-39188) was used in western blot on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (6E10)
  • western blot; human
BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples . Biochemistry (2015) ncbi
mouse monoclonal (6E10)
  • western blot; human
BioLegend APP antibody (Covance, SIG-39340) was used in western blot on human samples . J Neurosci (2015) ncbi
mouse monoclonal (6E10)
  • immunoprecipitation; human
BioLegend APP antibody (Covance, 6E10) was used in immunoprecipitation on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (4G8)
  • immunoprecipitation; human
BioLegend APP antibody (Covance, 4G8) was used in immunoprecipitation on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:500
BioLegend APP antibody (Signet, SIG-39300) was used in immunohistochemistry on mouse samples at 1:500. Brain Struct Funct (2016) ncbi
mouse monoclonal (6E10)
  • western blot; rat
BioLegend APP antibody (Covance, 6E10) was used in western blot on rat samples . Biomed Res Int (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - free floating section; mouse
In order to explore a nonpharmacological approach, repeated scanning ultrasound treatments, for removing Abeta and restoring memory function in a mouse model of Alzheimer's disease, BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry - free floating section on mouse samples . Sci Transl Med (2015) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:2000
In order to explore a nonpharmacological approach, repeated scanning ultrasound treatments, for removing Abeta and restoring memory function in a mouse model of Alzheimer's disease, BioLegend APP antibody (Covance, 6E10) was used in western blot on mouse samples at 1:2000. Sci Transl Med (2015) ncbi
mouse monoclonal (4G8)
  • western blot; human; 1:500
In order to study neuroinflammation-related gene regulation during normal aging and in sporadic Alzheimer disease in mice, BioLegend APP antibody (Covance, 4G8) was used in western blot on human samples at 1:500. J Neuropathol Exp Neurol (2015) ncbi
mouse monoclonal (6E10)
  • western blot; rat; 1:500
In order to elucidate the cell types and mechanisms underlying TREM2's contribution to neurodegeneration, BioLegend APP antibody (Covance, 6E10) was used in western blot on rat samples at 1:500. J Exp Med (2015) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; loading ...; fig 6e
BioLegend APP antibody (biolegend, 803001) was used in western blot on mouse samples (fig 6e). Cell Death Differ (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; 1:400
BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry on human samples at 1:400. Neurobiol Aging (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; 1:1000
BioLegend APP antibody (Covance, SIG39220) was used in immunohistochemistry on human samples at 1:1000. F1000Res (2014) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:500
In order to assess the neuroprotective effect of quercetin administration in the triple transgenic Alzheimer's disease model mice, BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry on mouse samples at 1:500. Neuropharmacology (2015) ncbi
mouse monoclonal (C1/6.1)
  • western blot; mouse; 1:1000; fig 8
In order to characterize cognitive and neuropathological Alzheimer's disease markers in a novel mouse model, BioLegend APP antibody (Covance, SIG-39152) was used in western blot on mouse samples at 1:1000 (fig 8). Age (Dordr) (2015) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:600
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry - paraffin section on mouse samples at 1:600. Alzheimer Dis Assoc Disord (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; fig s2
In order to investigate the relationship between beta-amyloid plaques and microglia, BioLegend APP antibody (BioLegend, SIG-39200) was used in immunohistochemistry on mouse samples (fig s2). Nat Commun (2015) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; rat
  • western blot; rat; 1:1000
BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry on rat samples and in western blot on rat samples at 1:1000. J Exerc Nutrition Biochem (2014) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; human; 1:300
  • ELISA; human; 1:1000
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry - paraffin section on human samples at 1:300 and in ELISA on human samples at 1:1000. Neuropathol Appl Neurobiol (2015) ncbi
mouse monoclonal (12F4)
  • ELISA; human; 1:500
BioLegend APP antibody (Covance, 12F4) was used in ELISA on human samples at 1:500. Neuropathol Appl Neurobiol (2015) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:1000
In order to investigate hypercholesterolemia at various stages of Alzheimer's disease, BioLegend APP antibody (Covance, SIG-39300) was used in immunohistochemistry on mouse samples at 1:1000. Mol Cell Neurosci (2014) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; 1:150
BioLegend APP antibody (Covance, Sig-39220) was used in immunohistochemistry on mouse samples at 1:150. Neurosci Lett (2015) ncbi
mouse monoclonal (6E10)
  • western blot; human; 1:1000
BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - frozen section; rat; 1:4000
BioLegend APP antibody (Signet, #39240) was used in immunohistochemistry - frozen section on rat samples at 1:4000. Adv Alzheimer Dis (2014) ncbi
mouse monoclonal (4G8)
  • western blot; human; 1:1000
In order to discuss decontaminating medical devices of pathological amyloid-beta-, tau- and alpha-synuclein aggregates, BioLegend APP antibody (Covance, SIG-39220) was used in western blot on human samples at 1:1000. Acta Neuropathol Commun (2014) ncbi
mouse monoclonal (6E10)
  • western blot; human; 1:2000
In order to discuss decontaminating medical devices of pathological amyloid-beta-, tau- and alpha-synuclein aggregates, BioLegend APP antibody (Covance, SIG-39320) was used in western blot on human samples at 1:2000. Acta Neuropathol Commun (2014) ncbi
mouse monoclonal (4G8)
  • immunocytochemistry; mouse; 1:1000
BioLegend APP antibody (Covance, 4G8) was used in immunocytochemistry on mouse samples at 1:1000. Neurobiol Aging (2015) ncbi
mouse monoclonal (C1/6.1)
  • western blot; mouse; 1:1000
BioLegend APP antibody (Covance, C1/6.1) was used in western blot on mouse samples at 1:1000. Neurobiol Aging (2015) ncbi
mouse monoclonal (6E10)
  • immunocytochemistry; mouse; 1:1000
  • western blot; mouse; 1:1000
BioLegend APP antibody (Covance, 6E10) was used in immunocytochemistry on mouse samples at 1:1000 and in western blot on mouse samples at 1:1000. Neurobiol Aging (2015) ncbi
mouse monoclonal (6E10)
  • western blot; rhesus macaque; 1:1000
In order to study the impact of amyloid-beta oligomers in the brains of rats and adult cynomolgus macaques, BioLegend APP antibody (Covance, SIG-39300-200) was used in western blot on rhesus macaque samples at 1:1000. J Neurosci (2014) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - free floating section; rat; 1:200
In order to study the impact of amyloid-beta oligomers in the brains of rats and adult cynomolgus macaques, BioLegend APP antibody (Covance, SIG-39220-200) was used in immunohistochemistry - free floating section on rat samples at 1:200. J Neurosci (2014) ncbi
mouse monoclonal (6E10)
  • immunocytochemistry; human
  • ELISA; human
  • western blot; human
BioLegend APP antibody (Covance, 6E10) was used in immunocytochemistry on human samples , in ELISA on human samples and in western blot on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - free floating section; mouse; 1:250
In order to investigate the role of membrane-anchored versus soluble CX3CL1 in regulating the microglia-mediated amelioration of Abeta pathology, BioLegend APP antibody (Signet Laboratories, SIG-39200-1000) was used in immunohistochemistry - free floating section on mouse samples at 1:250. J Neurosci (2014) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - free floating section; human; 1:2500
  • western blot; human; 1:2500
In order to correlate TREM2 expression with neurodegenerative markers in Alzheimer's disease, BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry - free floating section on human samples at 1:2500 and in western blot on human samples at 1:2500. Brain Pathol (2015) ncbi
mouse monoclonal (C1/6.1)
  • western blot; human; fig 1
In order to characterize brain aging in Alzheimer's disease and the biochemical properties of precuneus and posterior cingulate gyrus in the brain, BioLegend APP antibody (Covance, SIG-39152) was used in western blot on human samples (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (1G6)
  • western blot; human; fig 1
In order to characterize brain aging in Alzheimer's disease and the biochemical properties of precuneus and posterior cingulate gyrus in the brain, BioLegend APP antibody (Covance, SIG-39180) was used in western blot on human samples (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (6E10)
  • immunocytochemistry; mouse
In order to assess the effect of aging on brain lipoxin A4 levels using non-transgenic and 3xTg-AD mice, BioLegend APP antibody (Covance, 6E10) was used in immunocytochemistry on mouse samples . J Alzheimers Dis (2015) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; mouse; 1 ng/ ul
  • ELISA; mouse
BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry on mouse samples at 1 ng/ ul and in ELISA on mouse samples . J Biol Chem (2014) ncbi
mouse monoclonal (6E10)
  • ELISA; mouse
BioLegend APP antibody (Covance, 6E10) was used in ELISA on mouse samples . J Biol Chem (2014) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to investigate the relationship between ZnT3 and PSD95, cognition and pathology, BioLegend APP antibody (Covance, SIG-39220-200) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Neurobiol Aging (2014) ncbi
mouse monoclonal (4G8)
  • immunoprecipitation; human
  • ELISA; human
  • western blot; human
In order to discuss the effects of BMS-869780, a gamma secretase inhibitor, in several animal models, BioLegend APP antibody (Covance, 4G8) was used in immunoprecipitation on human samples , in ELISA on human samples and in western blot on human samples . Int J Alzheimers Dis (2014) ncbi
mouse monoclonal (6E10)
  • immunocytochemistry; human; 1:50
In order to assess the presence of granulovacuolar degeneration and the activated unfolded protein response in two mouse models of Alzheimer's disease, BioLegend APP antibody (Covance, 6E10) was used in immunocytochemistry on human samples at 1:50. Neurobiol Dis (2014) ncbi
mouse monoclonal (6E10)
  • western blot; human
In order to study the relationship of an Alzheimer's disease-linked SNP in the CLU gene and Tau, BioLegend APP antibody (Covance, SIG-39320) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:2000
  • western blot; rat; 1:2000
In order to investigate the mechanism for the neuroprotective effect of Klotho, BioLegend APP antibody (Covance, SIG-39300) was used in western blot on mouse samples at 1:2000 and in western blot on rat samples at 1:2000. J Biol Chem (2014) ncbi
mouse monoclonal (6E10)
  • western blot; human; 1:5000
BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples at 1:5000. PLoS ONE (2014) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:2500
In order to study the role of soluble mutant amyloid precursor protein on cognitive function and synaptic structure, BioLegend APP antibody (Covance, SIG-39340) was used in western blot on mouse samples at 1:2500. J Neurosci (2014) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:500
In order to study the role of exagerated Ca(2+) signaling mediated by InsP3 receptor1 in the pathogenesis of mutant presenilin-linked Alzheimer's disease, BioLegend APP antibody (Covance, 6E10) was used in western blot on mouse samples at 1:500. J Neurosci (2014) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry - frozen section; mouse; 1:500
BioLegend APP antibody (Covance, SIG-39220) was used in immunohistochemistry - frozen section on mouse samples at 1:500. J Alzheimers Dis (2014) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; human; 1 ug/ml
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry on human samples at 1 ug/ml. J Alzheimers Dis (2014) ncbi
mouse monoclonal (6E10)
  • western blot; human; 1:1000
BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples at 1:1000. Nanomedicine (2014) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - free floating section; mouse
  • western blot; mouse
BioLegend APP antibody (Covance Research Products, 6E10) was used in immunohistochemistry - free floating section on mouse samples and in western blot on mouse samples . Am J Pathol (2014) ncbi
mouse monoclonal (6E10)
  • western blot; human
In order to evaluate a novel insulin/IGF signaling pathway inhibitor for its protective effect on age-onset, neurodegeneration-linked proteotoxicity, BioLegend APP antibody (Covance, SIG-39320) was used in western blot on human samples . Aging Cell (2014) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; mouse; 1:1500
BioLegend APP antibody (Covance Inc., 6E10) was used in immunohistochemistry - frozen section on mouse samples at 1:1500. Acta Neuropathol Commun (2013) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - free floating section; mouse; 1:2000
BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry - free floating section on mouse samples at 1:2000. J Alzheimers Dis (2014) ncbi
mouse monoclonal (6E10)
  • immunoprecipitation; mouse
In order to investigate the role of microglial derived tumor necrosis factor alpha in neuronal cell cycle progression, BioLegend APP antibody (Covance, SIG-39300) was used in immunoprecipitation on mouse samples . Neurobiol Dis (2014) ncbi
mouse monoclonal (6E10)
  • western blot; mouse; 1:1000
In order to study Abeta agggregation and oligomerization induced in a murine model of Alzheimer's disease by experimental traumatic brain injury, BioLegend APP antibody (Covance, SIG-39320) was used in western blot on mouse samples at 1:1000. J Neurotrauma (2014) ncbi
mouse monoclonal (6E10)
  • western blot; human; 1:1000
In order to study the role of NG2 oligodendroglial precursor cells in the autophagic removal of Abeta peptides, BioLegend APP antibody (Signet, sig-39320) was used in western blot on human samples at 1:1000. Mol Neurodegener (2013) ncbi
mouse monoclonal (C1/6.1)
  • western blot; mouse; 1:1000
BioLegend APP antibody (Covance, SIG-39152) was used in western blot on mouse samples at 1:1000. Apoptosis (2013) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - paraffin section; mouse; 1:300
  • western blot; mouse; 1:1000
BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 and in western blot on mouse samples at 1:1000. Apoptosis (2013) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:200
BioLegend APP antibody (Signet, 6E10) was used in immunohistochemistry on mouse samples at 1:200. Transl Psychiatry (2013) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; human
In order to study the formation of amylin amyloid deposits in the cerebrovascular system and the implications for Alzheimer's disease, BioLegend APP antibody (Covance, 6E10) was used in immunohistochemistry on human samples . Ann Neurol (2013) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry - frozen section; human; 2 ug/ml
BioLegend APP antibody (Covance, SIG-39320) was used in immunohistochemistry - frozen section on human samples at 2 ug/ml. Neuropathol Appl Neurobiol (2014) ncbi
mouse monoclonal (4G8)
  • immunohistochemistry; human; 1:200
In order to study changes in autophagy and the roles of Tau hyperphosphorylation and fractalkine in an animal model of Abeta42-induced Tau hyperphosphorylation, BioLegend APP antibody (Covance, 4G8) was used in immunohistochemistry on human samples at 1:200. Exp Neurol (2014) ncbi
mouse monoclonal (6E10)
  • immunohistochemistry; mouse; 1:200
BioLegend APP antibody (Convance, SIG-39320) was used in immunohistochemistry on mouse samples at 1:200. J Alzheimers Dis (2013) ncbi
mouse monoclonal (4G8)
In order to study the mechanism by which Gas1 blocks the intracellular trafficking of amyloid precursor protein, BioLegend APP antibody (Signet, 4G8) was used . J Alzheimers Dis (2012) ncbi
mouse monoclonal (6E10)
  • western blot; human
In order to investigate the role of growth arrest-specific 1 in Alzheimer's disease, BioLegend APP antibody (Signet, 6E10) was used in western blot on human samples . Hum Mol Genet (2011) ncbi
mouse monoclonal (4G8)
  • immunoprecipitation; mouse
In order to investigate the role of growth arrest-specific 1 in Alzheimer's disease, BioLegend APP antibody (Signet, 4G8) was used in immunoprecipitation on mouse samples . Hum Mol Genet (2011) ncbi
mouse monoclonal (6E10)
  • western blot; human
BioLegend APP antibody (Covance, 6E10) was used in western blot on human samples . Neurobiol Aging (2012) ncbi
Invitrogen
domestic rabbit polyclonal (CT695)
  • western blot knockout validation; mouse; 1:250; loading ...; fig s1
Invitrogen APP antibody (Invitrogen, 51-2700) was used in western blot knockout validation on mouse samples at 1:250 (fig s1). Aging (Albany NY) (2021) ncbi
domestic rabbit polyclonal (CT695)
  • western blot; human
Invitrogen APP antibody (Invitrogen, 51-2700) was used in western blot on human samples . Acta Neuropathol Commun (2021) ncbi
domestic rabbit polyclonal (CT695)
  • immunohistochemistry; mouse; ; loading ...; fig 3b
Invitrogen APP antibody (hermoFisher, 51-2700) was used in immunohistochemistry on mouse samples at (fig 3b). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (22C11)
  • immunohistochemistry - paraffin section; rat; 1:250; loading ...; fig 6a
Invitrogen APP antibody (Thermo Fisher, 22C11) was used in immunohistochemistry - paraffin section on rat samples at 1:250 (fig 6a). Histochem Cell Biol (2019) ncbi
mouse monoclonal (NAB228)
  • immunocytochemistry; human; loading ...; fig 2a
  • western blot; human; loading ...; fig 1b
Invitrogen APP antibody (ThermoFisher Scientific, NAB228) was used in immunocytochemistry on human samples (fig 2a) and in western blot on human samples (fig 1b). J Biol Chem (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s1a
Invitrogen APP antibody (Zymed/Thermo Fisher Scientific, 71-5800) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s1a). Am J Pathol (2018) ncbi
domestic rabbit recombinant (H31L21)
  • immunohistochemistry - frozen section; African green monkey; 1:2500; loading ...; fig 1d
Invitrogen APP antibody (Invitrogen, 700254) was used in immunohistochemistry - frozen section on African green monkey samples at 1:2500 (fig 1d). Neurobiol Aging (2017) ncbi
domestic rabbit recombinant (H31L21)
  • western blot; human; loading ...; fig 6b
Invitrogen APP antibody (Invitrogen, 700254) was used in western blot on human samples (fig 6b). PLoS Genet (2017) ncbi
domestic rabbit recombinant (H31L21)
  • immunohistochemistry - free floating section; mouse; 1:200; loading ...; fig st1
In order to characterize physiological conformations of Abeta and amyloid precursor protein, Invitrogen APP antibody (Invitrogen, 700254) was used in immunohistochemistry - free floating section on mouse samples at 1:200 (fig st1). Nat Commun (2017) ncbi
mouse monoclonal (mAbP2-1)
  • western blot; mouse; 1:1000; loading ...; fig st1
In order to characterize physiological conformations of Abeta and amyloid precursor protein, Invitrogen APP antibody (ThermoFisher, OMA1-03132) was used in western blot on mouse samples at 1:1000 (fig st1). Nat Commun (2017) ncbi
domestic rabbit polyclonal (CT695)
  • immunohistochemistry - frozen section; pigs ; 1:250; loading ...; fig 1a
In order to characterize gyrencephalic swine brains exposed to true open field blasts, Invitrogen APP antibody (Life Technologies, 51-2700) was used in immunohistochemistry - frozen section on pigs samples at 1:250 (fig 1a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:2500; loading ...; fig 4a
In order to assess the effects of choline using a mouse model of Alzheimer's disease, Invitrogen APP antibody (Invitrogen, 44-344) was used in immunohistochemistry on mouse samples at 1:2500 (fig 4a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; African green monkey; 1:200; loading ...; fig 1h
In order to evaluate cellular markers associated with neurodegenerative diseases in common marmoset (Callithrix jacchus) brains, Invitrogen APP antibody (Invitrogen, 44136) was used in immunohistochemistry - frozen section on African green monkey samples at 1:200 (fig 1h). Front Aging Neurosci (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; African green monkey; 1:200; loading ...; fig 1f
In order to evaluate cellular markers associated with neurodegenerative diseases in common marmoset (Callithrix jacchus) brains, Invitrogen APP antibody (Invitrogen, 44344) was used in immunohistochemistry - frozen section on African green monkey samples at 1:200 (fig 1f). Front Aging Neurosci (2016) ncbi
mouse monoclonal (mAbP2-1)
  • ELISA; human
In order to describe an alternative aminomethyl linker for beta-secretase inhibitors that with potency similar to the current anilide moiety and improves brain penetration, Invitrogen APP antibody (Affinity BioReagents, OMA1-03132) was used in ELISA on human samples . J Med Chem (2017) ncbi
domestic rabbit polyclonal (CT695)
  • immunohistochemistry - free floating section; mouse; loading ...; fig 2e
In order to describe functional and structural pathology-to-network signatures in the brain after cuprizone treatment, Invitrogen APP antibody (Invitrogen, 51-2700) was used in immunohistochemistry - free floating section on mouse samples (fig 2e). Neuroimage (2017) ncbi
domestic rabbit recombinant (H31L21)
  • ELISA; human; loading ...; fig 1a
In order to investigate if amyloid beta 40 or 42 is related to sustaining a traumatic brain injury or to chronic neurological symptoms in a young cohort of military personnel, Invitrogen APP antibody (Invitrogen, H31L21) was used in ELISA on human samples (fig 1a). Brain Inj (2016) ncbi
mouse monoclonal (BAM01 (6F/3D))
  • immunohistochemistry; human; 1:100; loading ...; tbl 1
In order to characterize preclinical subjects with corticobasal degeneration, Invitrogen APP antibody (Biosource international, 6F/3D) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Brain (2016) ncbi
domestic rabbit recombinant (H31L21)
  • dot blot; mouse; 1:1000; loading ...; fig 6a
  • immunohistochemistry; mouse; 1:500; loading ...; fig 6b
In order to identify autophagy-inducing phytochemicals, Invitrogen APP antibody (Invitrogen, 700254) was used in dot blot on mouse samples at 1:1000 (fig 6a) and in immunohistochemistry on mouse samples at 1:500 (fig 6b). Autophagy (2017) ncbi
domestic rabbit polyclonal (CT695)
  • western blot; human; loading ...; fig 3b
In order to suggest that loss of the Wnt signaling pathway may contribute to Alzheimer's disease pathogenesis, Invitrogen APP antibody (Invitrogen, 51-2700) was used in western blot on human samples (fig 3b). J Neurochem (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:1000; loading ...; fig 4d
In order to discuss the role of corticotropin-releasing factor in the sex bias of some neuropsychiatric and neurodegenerative disorders, Invitrogen APP antibody (ThermoFisher Scientific, 44136) was used in immunohistochemistry on human samples at 1:1000 (fig 4d). Mol Psychiatry (2017) ncbi
mouse monoclonal (mAbP2-1)
  • ELISA; human
In order to demonstrate that cathepsin D is an off-target of BACE1 inhibitors in human cells, Invitrogen APP antibody (Affinity BioReagents, OMA1-03132) was used in ELISA on human samples . Nat Commun (2016) ncbi
domestic rabbit polyclonal (CT695)
  • western blot; mouse; loading ...; fig 3a
In order to show that Egr-1 plays role in BACE-1 activation, Invitrogen APP antibody (Invitrogen, 51-2700) was used in western blot on mouse samples (fig 3a). J Biol Chem (2016) ncbi
domestic rabbit recombinant (H31L21)
  • immunohistochemistry; mouse; loading ...; fig 2a
  • ELISA; mouse; loading ...; fig 5a
  • western blot; mouse; loading ...; fig 1f
In order to report that reduced exosome secretion due to nSMase2 loss improves pathology and cognition in a mouse model of Alzheimer's disease, Invitrogen APP antibody (ThermoFisher, H31L21) was used in immunohistochemistry on mouse samples (fig 2a), in ELISA on mouse samples (fig 5a) and in western blot on mouse samples (fig 1f). J Neurosci (2016) ncbi
domestic rabbit recombinant (H31L21)
  • immunohistochemistry; mouse; loading ...; fig 7e
In order to propose that the fornix plays a role in Alzheimer's disease, Invitrogen APP antibody (Life Technology, H31L21) was used in immunohistochemistry on mouse samples (fig 7e). Neuroimage (2016) ncbi
domestic rabbit polyclonal
  • other; human; 1:300; fig 2
In order to study a novel platform based on the planar frequency mixing magnetic technique that is a magnetic immunoassay, Invitrogen APP antibody (Invitrogen, 44-344) was used in other on human samples at 1:300 (fig 2). Biosens Bioelectron (2016) ncbi
domestic rabbit recombinant (H31L21)
  • immunocytochemistry; mouse; 1:600; loading ...; fig 1b
In order to test if the beta-amyloid peptide disrupts microtubules, Invitrogen APP antibody (ThermoFisher, 700254) was used in immunocytochemistry on mouse samples at 1:600 (fig 1b). Acta Neuropathol (2016) ncbi
domestic rabbit recombinant (H31L21)
  • immunohistochemistry - free floating section; human; 1:100; tbl 2
In order to characterize the frontal cortex of wild mountain gorillas (Gorilla beringei beringei) for early Alzheimer's disease-type pathology, Invitrogen APP antibody (Invitrogen, 700254) was used in immunohistochemistry - free floating section on human samples at 1:100 (tbl 2). Neurobiol Aging (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - free floating section; mouse; 1:1000; fig 4
In order to characterize chronic white matter inflammation and dendritic spine loss in a mouse model of highly repetitive head trauma, Invitrogen APP antibody (Invitrogen, 36-6900) was used in immunohistochemistry - free floating section on mouse samples at 1:1000 (fig 4). Am J Pathol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100; fig 1
In order to study colocalization of A-beta pathology in Alzheimer's disease mouse models with catalytically active tissue transglutaminase, Invitrogen APP antibody (Invitrogen, 715800) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1). Sci Rep (2016) ncbi
domestic rabbit polyclonal (CT695)
  • immunocytochemistry; longfin inshore squid; fig 1
In order to characterize organelles that bind microtubules in an ATP dependent manner by studying the amyloid precursor protein of Alzheimer's disease clusters at the organelle/microtubule interface, Invitrogen APP antibody (Invitrogen, 51-C2700) was used in immunocytochemistry on longfin inshore squid samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (LN27)
  • western blot; human; 1:500; fig 3
In order to study cargo deficits in multiple sclerosis lesional and normal-appearing white matter for the axonal motor protein KIF5A, Invitrogen APP antibody (Zymed, 13-0200) was used in western blot on human samples at 1:500 (fig 3). Neuropathol Appl Neurobiol (2017) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry; human; fig 7
In order to analyze chemogenetic modulation of neural activity by attenuation of beta-amyloid deposition and neurotoxicity, Invitrogen APP antibody (Thermo Fisher, LN27) was used in immunohistochemistry on human samples (fig 7). J Neurosci (2016) ncbi
domestic rabbit polyclonal (CT695)
In order to assess the deletion of Ccr2 and cavity size and tau pathology after mild traumatic brain injury, Invitrogen APP antibody (Invitrogen, 51-2700) was used . J Neuroinflammation (2015) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; tbl 1
In order to determine how an increase in synapse AMPA subuit and amelioration of spatial memory deficits occurs by TrkB activation by 7,8-dihydroxyflavone in a mouse model of Alzheimer's disease, Invitrogen APP antibody (Thermo Scientific, PA3-16760) was used in western blot on mouse samples at 1:500 (tbl 1). J Neurochem (2016) ncbi
domestic rabbit polyclonal
In order to investigate the contribution of TRPM2 to beta-amyloid neuronal toxicity, Invitrogen APP antibody (Invitrogen, 44344) was used . J Neurosci (2015) ncbi
domestic rabbit polyclonal (CT695)
In order to assess Losartan treatment on experimental glaucoma, Invitrogen APP antibody (Novex by Life Technologies, 512700) was used . PLoS ONE (2015) ncbi
domestic rabbit polyclonal (CT695)
In order to determine the relationship between injured axons after mild traumatic brain injury in pigs and microglia processes, Invitrogen APP antibody (Life Technologies, 51-2700) was used . J Neuroinflammation (2015) ncbi
mouse monoclonal (LN27)
  • western blot; human; 1:400
In order to investigate the role of cholesterol in the pathogenesis of Alzheimer's disease, Invitrogen APP antibody (Zymed, LN27) was used in western blot on human samples at 1:400. J Neurodegener Dis (2013) ncbi
domestic rabbit polyclonal (CT695)
In order to elucidate the mechanisms by which increased LMNB1 levels cause autosomal dominant leukodystrophy, Invitrogen APP antibody (Invitrogen, 512700) was used . J Neurosci (2015) ncbi
domestic rabbit polyclonal (CT695)
In order to show that IDN5706 promotes iAPP degradation by activating Atg5-dependent autophagy, Invitrogen APP antibody (Invitrogen, 51-2700) was used . PLoS ONE (2015) ncbi
mouse monoclonal (LN27)
  • western blot; mouse; 1:1000; fig 4
In order to analyze a mouse model where human neural stem cells alleviate Alzheimer-like pathology, Invitrogen APP antibody (Zymed, 130200) was used in western blot on mouse samples at 1:1000 (fig 4). Mol Neurodegener (2015) ncbi
domestic rabbit polyclonal
In order to demonstrate that liraglutide has prophylactic properties in Alzheimer's disease models, Invitrogen APP antibody (Invitrogen, 71-5800) was used . Behav Brain Res (2015) ncbi
domestic rabbit polyclonal
In order to study the role of apolipoprotein E in cerebral amyloid angiopathy, Invitrogen APP antibody (Invitrogen, 715800) was used . J Neurochem (2015) ncbi
domestic rabbit polyclonal
In order to classify subtypes of amyloid-beta oligomers, Invitrogen APP antibody (Invitrogen, 36-6900) was used . Cell Rep (2015) ncbi
domestic rabbit polyclonal (CT695)
In order to describe the development of a closed-body model of spinal cord injury in mice, Invitrogen APP antibody (Invitrogen, 51-2700) was used . Exp Neurol (2015) ncbi
domestic rabbit polyclonal
In order to investigate butyrylcholinesterase activity in a mouse model of Alzheimer's disease, Invitrogen APP antibody (Invitrogen, 71-5800) was used . Neuroscience (2015) ncbi
domestic rabbit recombinant (H31L21)
  • immunohistochemistry - frozen section; mouse
Invitrogen APP antibody (Invitrogen, H31L21) was used in immunohistochemistry - frozen section on mouse samples . J Neurosci (2015) ncbi
mouse monoclonal (mAbP2-1)
  • ELISA; human; fig 1
In order to generate BACE1 inhibitors for the treatment of Alzheimer's disease, Invitrogen APP antibody (Affinity BioReagents, OMA1-03132) was used in ELISA on human samples (fig 1). J Med Chem (2015) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to investigate the spread of neuronal pathology, Invitrogen APP antibody (Life Technologies, 13-0200) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Neuropathol Appl Neurobiol (2015) ncbi
mouse monoclonal (mAbP2-1)
  • ELISA; human; tbl 1
In order to generate and characterize new BACE1 inhibitors for the treatment of Alzheimer's disease, Invitrogen APP antibody (Affinity BioReagents, OMA1-03132) was used in ELISA on human samples (tbl 1). J Med Chem (2015) ncbi
domestic rabbit polyclonal (CT695)
In order to discuss the limitations assessing axonal injury by microscopy, Invitrogen APP antibody (Invitrogen, 51-2700) was used . J Neurosci Methods (2015) ncbi
domestic rabbit polyclonal (CT695)
In order to investigate the contribution of TREM2 to microglia function in vivo, Invitrogen APP antibody (Invitrogen, 51-2700) was used . Acta Neuropathol (2015) ncbi
domestic rabbit recombinant (H31L21)
  • immunohistochemistry - paraffin section; human; fig 4
In order to quantify amyloid beta 42 and paired helical filament-tau in the frontal, temporal, and parietal cortices, Invitrogen APP antibody (Invitrogen, 700254) was used in immunohistochemistry - paraffin section on human samples (fig 4). J Neuropathol Exp Neurol (2015) ncbi
domestic rabbit recombinant (H31L21)
  • ELISA; mouse; fig 3
  • western blot; mouse; 1:2500; fig 2
In order to test if reduction in BACE1 prevents or treats Alzheimer's disease, Invitrogen APP antibody (Invitrogen, 700254) was used in ELISA on mouse samples (fig 3) and in western blot on mouse samples at 1:2500 (fig 2). Mol Neurodegener (2015) ncbi
domestic rabbit polyclonal (CT695)
In order to characterize axonal injury over time, Invitrogen APP antibody (Invitrogen, 51-2700) was used . Acta Neuropathol (2015) ncbi
domestic rabbit polyclonal (CT695)
In order to examine the role of the monoaminergic system in mild blast-induced traumatic brain injury, Invitrogen APP antibody (Life Technologies, 51-2700) was used . J Neurotrauma (2015) ncbi
domestic rabbit polyclonal (CT695)
In order to report that Kal9 and Kal12 mediate dendritic maturation in early development, Invitrogen APP antibody (Life Technologies, 51-2700) was used . Cereb Cortex (2015) ncbi
domestic rabbit recombinant (H31L21)
  • immunocytochemistry; human; 1:2000
In order to investigate the contribution of GABA inhibition in the dentate gyrus in Alzheimer's disease, Invitrogen APP antibody (Invitrogen, 700254) was used in immunocytochemistry on human samples at 1:2000. Nat Commun (2014) ncbi
mouse monoclonal (BAM01 (6F/3D))
  • immunohistochemistry; human; 1:100
In order to investigate the protein expression of G-CSF and its receptor in the adult human brain, Invitrogen APP antibody (Pierce Biotechnology, Clone 6F/3D) was used in immunohistochemistry on human samples at 1:100. J Anat (2014) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry; rhesus macaque; fig 4
In order to explain how CCR5 antagonists may attenuate central nervous system disease by modulating inflammatory signaling and by limiting HIV replication, Invitrogen APP antibody (Zymed, Clone LN27) was used in immunohistochemistry on rhesus macaque samples (fig 4). AIDS (2013) ncbi
domestic rabbit recombinant (H31L21)
  • immunohistochemistry - frozen section; mouse; 1:500
In order to study Abeta agggregation and oligomerization induced in a murine model of Alzheimer's disease by experimental traumatic brain injury, Invitrogen APP antibody (Invitrogen, 700254) was used in immunohistochemistry - frozen section on mouse samples at 1:500. J Neurotrauma (2014) ncbi
domestic rabbit recombinant (H31L21)
  • immunocytochemistry; human
  • western blot; human
In order to study the role of NG2 oligodendroglial precursor cells in the autophagic removal of Abeta peptides, Invitrogen APP antibody (Invitrogen, 700254) was used in immunocytochemistry on human samples and in western blot on human samples . Mol Neurodegener (2013) ncbi
domestic rabbit recombinant (H31L21)
  • western blot; human; 1:2500
In order to study levels of BACE1 and Abeta42 in aged patients with cerebral atherosclerosis in the absence of dementia, Invitrogen APP antibody (Invitrogen, 700254) was used in western blot on human samples at 1:2500. Curr Alzheimer Res (2013) ncbi
mouse monoclonal (LN27)
  • western blot; human; fig 1
In order to identify agents that can reduce Abeta levels in the brain, Invitrogen APP antibody (Invitrogen, LN27) was used in western blot on human samples (fig 1). J Biol Chem (2013) ncbi
mouse monoclonal (LN27)
  • immunocytochemistry; human
In order to describe the intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system, Invitrogen APP antibody (Zymed, LN27) was used in immunocytochemistry on human samples . Transl Neurodegener (2012) ncbi
mouse monoclonal (LN27)
  • western blot; human; fig 6b
In order to elucidate the molecular linkage between epileptic seizures and Abeta generation in Alzheimer's disease, Invitrogen APP antibody (Zymed, LN27) was used in western blot on human samples (fig 6b). Mol Neurodegener (2012) ncbi
domestic rabbit polyclonal
In order to examine the effect on the anti-inflammatory, MW01-2-151SRM, in a mouse model of Alzheimer's disease, Invitrogen APP antibody (Invitrogen, 44338100) was used . J Neurosci (2012) ncbi
mouse monoclonal (LN27)
  • western blot; human; 1:1000; fig 3, 4
In order to study the role of receptor tyrosine kinase Tyro3 in APP processing and beta amyloid deposition, Invitrogen APP antibody (ZYMED, 13-0200) was used in western blot on human samples at 1:1000 (fig 3, 4). PLoS ONE (2012) ncbi
mouse monoclonal (LN27)
  • western blot; human; 1:250; fig 3
In order to elucidate the role of Kinesin-1 in Alzheimer disease pathogenesis, Invitrogen APP antibody (Invitrogen, LN27) was used in western blot on human samples at 1:250 (fig 3). PLoS ONE (2012) ncbi
domestic rabbit recombinant (H31L21)
  • ELISA; human; 0.1 ug/ml
In order to study the effects of hypoxia following cardiac arrest on Abeta42 serum levels in humans, Invitrogen APP antibody (Invitrogen, H31L21) was used in ELISA on human samples at 0.1 ug/ml. PLoS ONE (2011) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry; human; tbl 2
In order to investigate phagocytosis of neuronal antigens in a multiple sclerosis model, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry on human samples (tbl 2). Glia (2012) ncbi
mouse monoclonal (LN27)
  • immunocytochemistry; human; 1:100; fig 1
In order to study the contribution of macroautophagy to lysosomal Abeta accumulation, Invitrogen APP antibody (Zymed Laboratories, 13-0200) was used in immunocytochemistry on human samples at 1:100 (fig 1). Autophagy (2011) ncbi
mouse monoclonal (LN27)
  • western blot; human; fig 1
In order to study the mechanism by which Gas1 blocks the intracellular trafficking of amyloid precursor protein, Invitrogen APP antibody (Zymed Laboratories, LN27) was used in western blot on human samples (fig 1). J Alzheimers Dis (2012) ncbi
mouse monoclonal (LN27)
  • immunocytochemistry; mouse; fig 7
In order to identify and characterize LDL receptor class A domain containing 3, Invitrogen APP antibody (Zymed, clone LN27) was used in immunocytochemistry on mouse samples (fig 7). J Neurosci (2011) ncbi
mouse monoclonal (LN27)
  • immunocytochemistry; human
  • western blot; human
In order to investigate the role of growth arrest-specific 1 in Alzheimer's disease, Invitrogen APP antibody (Zymed Laboratories, LN27) was used in immunocytochemistry on human samples and in western blot on human samples . Hum Mol Genet (2011) ncbi
mouse monoclonal (LN27)
  • western blot; human
In order to compare the serum immunoglobulin G reactivity profiles obtained using the full spectrum of human myelin-associated proteins of multiple sclerosis patients and healthy control subjects, Invitrogen APP antibody (Zymed, clone LN27) was used in western blot on human samples . J Neuropathol Exp Neurol (2010) ncbi
mouse monoclonal (LN27)
  • immunocytochemistry; mouse
In order to investigate resveratrol's regulation of AMP-activated protein kinase, Invitrogen APP antibody (Zymed Laboratories, LN27) was used in immunocytochemistry on mouse samples . J Biol Chem (2010) ncbi
mouse monoclonal (LN27)
  • western blot; human
In order to search for N-terminal fragments of amyloid precursor protein in cerebrospinal fluid, Invitrogen APP antibody (Zymed, LN27) was used in western blot on human samples . Exp Neurol (2010) ncbi
mouse monoclonal (mAbP2-1)
  • immunoprecipitation; human
In order to search for N-terminal fragments of amyloid precursor protein in cerebrospinal fluid, Invitrogen APP antibody (BioSource, P2-1) was used in immunoprecipitation on human samples . Exp Neurol (2010) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; rhesus macaque; fig 1
In order to assess the relationship between expression of the MHC class I allele Mane-A*10 and development of lentiviral-induced central nervous system disease, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry - paraffin section on rhesus macaque samples (fig 1). PLoS ONE (2008) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry; human; fig 1
In order to study the case of a 61-year-old man with autosomal dominant sensory ataxia who died of congestive heart failure, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry on human samples (fig 1). Acta Neuropathol (2008) ncbi
mouse monoclonal (LN27)
  • immunocytochemistry; human; fig 2
In order to investigate the regulatory link between beta-amyloid precursor protein and dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A in Down syndrome brains, Invitrogen APP antibody (Zymed Laboratories, 13-0200) was used in immunocytochemistry on human samples (fig 2). J Neurochem (2008) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; rat; 1:200
In order to examine the role of calpain activation in the corpus callosum in traumatic brain injury, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry - paraffin section on rat samples at 1:200. J Neurotrauma (2007) ncbi
mouse monoclonal (LN27)
  • ELISA; human; 0.5 ug/ml
In order to test if sporadic cases of Alzheimer's disease are associated with changes in transcription of amyloid precursor protein or its metabolic partners, Invitrogen APP antibody (Zymed, LN27) was used in ELISA on human samples at 0.5 ug/ml. Brain Res (2007) ncbi
mouse monoclonal (LN27)
  • immunocytochemistry; human; 1:1000
In order to propose that amyloid precursor protein and presenilin1 are part of a common signaling pathway that regulates ERK1,2 and the cell cycle, Invitrogen APP antibody (Zymed, 13-0200) was used in immunocytochemistry on human samples at 1:1000. J Biol Chem (2007) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; human; 1:1500
  • immunohistochemistry - paraffin section; mouse; 1:1500; fig 8
In order to examine brain material from four fatal human cases of Japanese encephalitis virus infection, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry - paraffin section on human samples at 1:1500 and in immunohistochemistry - paraffin section on mouse samples at 1:1500 (fig 8). Trans R Soc Trop Med Hyg (2006) ncbi
mouse monoclonal (LN27)
  • western blot; rat; fig 2
In order to investigate the effect of L-glutamate treatment on the secreted form of amyloid precursor protein, Invitrogen APP antibody (Zymed, LN27) was used in western blot on rat samples (fig 2). Acta Biol Hung (2005) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry; rhesus macaque; 1:10000
In order to investigate the role 14-3-3 proteins in the pathogenesis of central nervous system, Invitrogen APP antibody (Zymed, Clone LN27) was used in immunohistochemistry on rhesus macaque samples at 1:10000. J Neuropathol Exp Neurol (2005) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; human; fig 5
In order to present the case of a Japanese patient who had a prion protein gene mutation responsible for fatal familial insomnia, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry - paraffin section on human samples (fig 5). Neuropathol Appl Neurobiol (2005) ncbi
mouse monoclonal (AMY-33)
  • ELISA; human
In order to use intracerebroventricular injection of anti-Abeta antibody to treat murine models of Alzheimer's disease, Invitrogen APP antibody (ZyMed, AMY-33) was used in ELISA on human samples . Expert Rev Vaccines (2004) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; mouse; fig 2
  • western blot; mouse; fig 2
In order to develop and characterize a new mouse model of Alzheimer's disease, Invitrogen APP antibody (Zymed, 13-0200) was used in immunohistochemistry - paraffin section on mouse samples (fig 2) and in western blot on mouse samples (fig 2). J Neurosci Res (2004) ncbi
mouse monoclonal (LN27)
  • ELISA; human
In order to determine the soluble molecules in cerebrospinal fluid that indicate axonal degeneration and amyloidogenesis, Invitrogen APP antibody (Zymed, LN27) was used in ELISA on human samples . Arthritis Res Ther (2004) ncbi
mouse monoclonal (LN27)
  • western blot; human; fig 1
In order to characterize mice that overexpress the Swedish double familial Alzheimer's disease mutation, Invitrogen APP antibody (Zymed, LN27) was used in western blot on human samples (fig 1). Neuroscience (2003) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; domestic sheep; fig 3
In order to describe a biomechanical study of axonal injury due to a blunt impact to the head, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry - paraffin section on domestic sheep samples (fig 3). J Neurotrauma (2003) ncbi
mouse monoclonal (LN27)
  • western blot; human; fig 3
In order to investigate the role of Alcadein in Alzheimer's disease, Invitrogen APP antibody (Zymed, LN27) was used in western blot on human samples (fig 3). J Biol Chem (2003) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry; human; tbl 2
In order to investigate HIV/SIV CNS infection and damage, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry on human samples (tbl 2). J Neurovirol (2003) ncbi
mouse monoclonal (mAbP2-1)
  • ELISA; human; 0.25 ug/ml
In order to investigate the role of the -YENP- motif of the amyloid precursor protein, Invitrogen APP antibody (Biosource, mAbP2-1) was used in ELISA on human samples at 0.25 ug/ml. Neuroscience (2003) ncbi
mouse monoclonal (AMY-33)
  • immunohistochemistry; rat; fig 4
In order to test if caspase-3-mediated cleavage of beta-amyloid precursor protein occurs in traumatic axonal injury, Invitrogen APP antibody (Zymed, AMY-33) was used in immunohistochemistry on rat samples (fig 4). J Neurotrauma (2002) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry; pigtail macaque; fig 1
In order to investigate the mechanisms of axonal damage associated with HIV central nervous system infection, Invitrogen APP antibody (Zymed Laboratories, Clone LN27) was used in immunohistochemistry on pigtail macaque samples (fig 1). J Neuropathol Exp Neurol (2002) ncbi
mouse monoclonal (LN27)
  • western blot; human; fig 6
In order to determine the role of endocytic compartments in beta-secretase processing of amyloid precursor protein, Invitrogen APP antibody (Zymed, clone LN27) was used in western blot on human samples (fig 6). Traffic (2001) ncbi
mouse monoclonal (LN27)
  • ELISA; human
In order to examine MG132 inhibition of beta-secretase cleavage, Invitrogen APP antibody (Zymed, LN27) was used in ELISA on human samples . J Biol Chem (2001) ncbi
mouse monoclonal (LN27)
  • immunoprecipitation; human; fig 3
  • western blot; human; fig 8
In order to elucidate the regulatory role of human bleomycin hydrolase in the amyloid precursor protein processing pathways, Invitrogen APP antibody (Zymed Laboratories, clone LN27) was used in immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 8). FASEB J (2000) ncbi
mouse monoclonal (LN27)
  • immunocytochemistry; human; fig 8
In order to characterize human X11-like, Invitrogen APP antibody (Zymed, LN27) was used in immunocytochemistry on human samples (fig 8). J Biol Chem (1999) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:200; fig 1
  • western blot; domestic rabbit; 1:1000; fig 2
In order to study aluminum maltolate-induced neurofibrillary degeneration in rabbits, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:200 (fig 1) and in western blot on domestic rabbit samples at 1:1000 (fig 2). Brain Res (1997) ncbi
mouse monoclonal (AMY-33)
  • immunoprecipitation; human; fig 3
In order to examine beta-amyloid formation and its inhibition, Invitrogen APP antibody (Zymed, AMY-33) was used in immunoprecipitation on human samples (fig 3). Proc Natl Acad Sci U S A (1996) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; human; 1:200
In order to investigate markers of axonal injury, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry - paraffin section on human samples at 1:200. Acta Neuropathol (1994) ncbi
mouse monoclonal (LN27)
  • immunohistochemistry - paraffin section; human; 1:200
In order to study 3B11 immunoreactivity in the human brain, Invitrogen APP antibody (Zymed, LN27) was used in immunohistochemistry - paraffin section on human samples at 1:200. Biochem J (1995) ncbi
Abcam
domestic rabbit monoclonal (mOC64)
  • western blot; human; loading ...; fig 4a
  • immunohistochemistry; rhesus macaque; loading ...; fig 2a, 2b
  • western blot; rhesus macaque; loading ...; fig 1a, 1b
Abcam APP antibody (Abcam, ab201060) was used in western blot on human samples (fig 4a), in immunohistochemistry on rhesus macaque samples (fig 2a, 2b) and in western blot on rhesus macaque samples (fig 1a, 1b). Aging Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4b
Abcam APP antibody (Abcam, ab15272) was used in western blot on human samples (fig 4b). Aging Dis (2021) ncbi
domestic rabbit monoclonal (mOC64)
  • western blot; mouse; 1:1000; loading ...; fig 5a
Abcam APP antibody (Abcam, ab201060) was used in western blot on mouse samples at 1:1000 (fig 5a). PLoS ONE (2021) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry; mouse; 1:500; loading ...
Abcam APP antibody (Abcam, ab32136) was used in immunohistochemistry on mouse samples at 1:500. Acta Neuropathol Commun (2020) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; mouse; 1:1000; loading ...; fig 5a
Abcam APP antibody (Abcam, ab32136) was used in western blot on mouse samples at 1:1000 (fig 5a). Acta Neuropathol Commun (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 5a
Abcam APP antibody (Abcam, ab2072) was used in western blot on mouse samples at 1:1000 (fig 5a). Acta Neuropathol Commun (2020) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry - frozen section; mouse; 1:150; loading ...; fig 3b
  • western blot; mouse; 1:2000; loading ...; fig 3f
Abcam APP antibody (Abcam, ab32136) was used in immunohistochemistry - frozen section on mouse samples at 1:150 (fig 3b) and in western blot on mouse samples at 1:2000 (fig 3f). Front Aging Neurosci (2020) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 5a, 5d
Abcam APP antibody (Abcam, ab32136) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 5a, 5d). Sci Adv (2020) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry - paraffin section; mouse; 1:15,000; loading ...; fig 4
Abcam APP antibody (Abcam, ab32136) was used in immunohistochemistry - paraffin section on mouse samples at 1:15,000 (fig 4). J Neurotrauma (2020) ncbi
mouse monoclonal (MOAB-2)
  • immunohistochemistry - frozen section; mouse; 1:400; loading ...; fig 1b
Abcam APP antibody (Abcam, ab126649) was used in immunohistochemistry - frozen section on mouse samples at 1:400 (fig 1b). Nat Commun (2019) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4c
  • immunocytochemistry; mouse; 1:200; loading ...; fig 1b
  • western blot; mouse; loading ...; fig 1c
  • immunocytochemistry; human; 1:200; fig 2b
  • western blot; human; loading ...; fig 2c
Abcam APP antibody (Abcam, ab32136) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4c), in immunocytochemistry on mouse samples at 1:200 (fig 1b), in western blot on mouse samples (fig 1c), in immunocytochemistry on human samples at 1:200 (fig 2b) and in western blot on human samples (fig 2c). Nat Commun (2019) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; human; loading ...; fig 1b
Abcam APP antibody (Abcam, ab32136) was used in western blot on human samples (fig 1b). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry; mouse; loading ...; fig 5
Abcam APP antibody (Abcam, Y188) was used in immunohistochemistry on mouse samples (fig 5). Front Cell Neurosci (2018) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; mouse; loading ...; fig 1a
Abcam APP antibody (Abcam, ab32136) was used in western blot on mouse samples (fig 1a). Sci Transl Med (2018) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; mouse; 1:2000; loading ...; fig 4b
Abcam APP antibody (Abcam, Y188) was used in western blot on mouse samples at 1:2000 (fig 4b). Mol Neurodegener (2018) ncbi
domestic rabbit monoclonal (mOC64)
  • western blot; mouse; loading ...; fig 3f
Abcam APP antibody (Abcam, ab201060) was used in western blot on mouse samples (fig 3f). Neurotherapeutics (2018) ncbi
domestic rabbit monoclonal (Y188)
  • immunocytochemistry; pigs ; loading ...; fig 5d
  • immunocytochemistry; human; fig 7a
In order to study amyloid precursor protein Tyr phosphorylation in mouse model of Alzheimer's disease, Abcam APP antibody (Abcam, ab32136) was used in immunocytochemistry on pigs samples (fig 5d) and in immunocytochemistry on human samples (fig 7a). Front Mol Neurosci (2017) ncbi
mouse monoclonal (DE2B4)
  • immunocytochemistry; pigs ; loading ...
In order to study amyloid precursor protein Tyr phosphorylation in mouse model of Alzheimer's disease, Abcam APP antibody (Abcam, ab11132) was used in immunocytochemistry on pigs samples . Front Mol Neurosci (2017) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; mouse; loading ...; fig 5b
Abcam APP antibody (Abcam, ab32136) was used in western blot on mouse samples (fig 5b). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4a
Abcam APP antibody (Abcam, ab15272) was used in western blot on human samples (fig 4a). elife (2017) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 1e
  • western blot knockout validation; mouse; loading ...; fig 2
  • immunohistochemistry - free floating section; mouse; loading ...; fig 1d
Abcam APP antibody (Epitomics, ab32136) was used in immunohistochemistry knockout validation on mouse samples (fig 1e), in western blot knockout validation on mouse samples (fig 2) and in immunohistochemistry - free floating section on mouse samples (fig 1d). Front Mol Neurosci (2016) ncbi
domestic rabbit monoclonal (Y188)
  • immunocytochemistry; human; 1:200; loading ...; fig 1a
In order to investigate how familial Alzheimer's disease mutations affect endocytosis, Abcam APP antibody (Abcam, ab32136) was used in immunocytochemistry on human samples at 1:200 (fig 1a). Cell Rep (2016) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; human; 1:1000; fig 3
Abcam APP antibody (Abcam, ab32136) was used in western blot on human samples at 1:1000 (fig 3). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 4
  • western blot; rat; 1:1000; fig 3
Abcam APP antibody (Abcam, ab32136) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 4) and in western blot on rat samples at 1:1000 (fig 3). Neural Regen Res (2016) ncbi
mouse monoclonal (DE2B4)
  • western blot; human; fig 1
Abcam APP antibody (Abcam, ab11132) was used in western blot on human samples (fig 1). Aging Cell (2016) ncbi
domestic rabbit monoclonal (Y188)
In order to study behavioral deficits without pathological interaction by humanized tau mice with regionalized amyloid, Abcam APP antibody (Abcam, ab32136) was used . PLoS ONE (2016) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; human; 1:4000; fig 1
Abcam APP antibody (Abcam, ab32136) was used in western blot on human samples at 1:4000 (fig 1). EMBO Mol Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; fig 2
In order to research blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer's brains by pharmacological profiling of the novel modulator of the alpha7 nicotinic receptor, Abcam APP antibody (Abcam, ab2072) was used in western blot on rat samples at 1:1000 (fig 2). Neuropharmacology (2016) ncbi
domestic rabbit monoclonal (Y188)
  • immunocytochemistry; mouse; loading ...; fig 3a
Abcam APP antibody (Abcam, ab32136) was used in immunocytochemistry on mouse samples (fig 3a). Nat Neurosci (2016) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; rat; 1:5000
In order to localize ADAM10 and BACE1 in synaptic vesicles, Abcam APP antibody (Abcam, ab32136) was used in western blot on rat samples at 1:5000. J Neurochem (2015) ncbi
mouse monoclonal (BDI350)
  • western blot; mouse
Abcam APP antibody (Abcam, ab20068) was used in western blot on mouse samples . J Inorg Biochem (2015) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry; mouse; 1:1000
Abcam APP antibody (Abcam, ab32136) was used in immunohistochemistry on mouse samples at 1:1000. J Neuroimmunol (2015) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; 1:1000; loading ...; fig 3a
Abcam APP antibody (Abcam, Ab32136) was used in immunohistochemistry on mouse samples (fig 3c) and in western blot on mouse samples at 1:1000 (fig 3a). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (Y188)
  • ELISA; human; tbl 4
  • western blot; human; tbl 4
  • western blot; mouse; tbl 3
Abcam APP antibody (Abcam, ab32136) was used in ELISA on human samples (tbl 4), in western blot on human samples (tbl 4) and in western blot on mouse samples (tbl 3). Biogerontology (2015) ncbi
domestic rabbit monoclonal (Y188)
  • immunohistochemistry - paraffin section; mouse
  • immunoprecipitation; mouse
  • western blot; mouse
Abcam APP antibody (Abcam, Y188) was used in immunohistochemistry - paraffin section on mouse samples , in immunoprecipitation on mouse samples and in western blot on mouse samples . Front Cell Neurosci (2015) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; mouse; 1:1000
In order to assess the effect of CD11b-positive (+) monocytes on Alzheimer's disease using a mouse model, Abcam APP antibody (Abcam, ab32136) was used in western blot on mouse samples at 1:1000. PLoS ONE (2015) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000
Abcam APP antibody (Abcam, ab15272) was used in western blot on rat samples at 1:1000. Mol Neurobiol (2016) ncbi
domestic rabbit monoclonal (Y188)
  • immunocytochemistry; human
Abcam APP antibody (Abcam, Y188) was used in immunocytochemistry on human samples . J Biol Chem (2014) ncbi
domestic rabbit monoclonal (Y188)
  • western blot; mouse
Abcam APP antibody (Abcam, Y188) was used in western blot on mouse samples . J Neurosci (2014) ncbi
mouse monoclonal (DE2B4)
  • immunohistochemistry - free floating section; mouse
Abcam APP antibody (Abcam, AB11132) was used in immunohistochemistry - free floating section on mouse samples . Brain Behav (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (B-4)
  • western blot; human; 1:1000; loading ...
Santa Cruz Biotechnology APP antibody (Santa Cruz, SC-28365) was used in western blot on human samples at 1:1000. Nat Commun (2021) ncbi
mouse monoclonal (NAB228)
  • immunohistochemistry - free floating section; mouse; 1:2000; loading ...; fig 9a
Santa Cruz Biotechnology APP antibody (Santa Cruz, sc-32277) was used in immunohistochemistry - free floating section on mouse samples at 1:2000 (fig 9a). elife (2020) ncbi
mouse monoclonal (B-4)
  • western blot; rat; 1:200; loading ...; fig 5a
Santa Cruz Biotechnology APP antibody (Santa Cruz Biotechnology, sc-28365) was used in western blot on rat samples at 1:200 (fig 5a). Neuropharmacology (2019) ncbi
mouse monoclonal (DE2B4)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 6a
Santa Cruz Biotechnology APP antibody (Santa Cruz, sc-58508) was used in immunohistochemistry on mouse samples at 1:250 (fig 6a). Cell Death Differ (2017) ncbi
mouse monoclonal (B-4)
  • western blot; rat; fig 5
Santa Cruz Biotechnology APP antibody (Santa Cruz, SC-28365) was used in western blot on rat samples (fig 5). Neural Plast (2016) ncbi
mouse monoclonal (DE2B4)
  • immunohistochemistry; fruit fly ; 1:200; fig 2P
Santa Cruz Biotechnology APP antibody (Santa Cruz, sc-58508) was used in immunohistochemistry on fruit fly samples at 1:200 (fig 2P). Dis Model Mech (2016) ncbi
mouse monoclonal (B-4)
  • proximity ligation assay; mouse; 2000 ng/ml; fig 5
  • western blot; mouse; 1000 ng/ml; fig 8
Santa Cruz Biotechnology APP antibody (Santa Cruz, sc-28365) was used in proximity ligation assay on mouse samples at 2000 ng/ml (fig 5) and in western blot on mouse samples at 1000 ng/ml (fig 8). Nat Commun (2015) ncbi
mouse monoclonal (20.1)
  • western blot; human
Santa Cruz Biotechnology APP antibody (Santa Cruz Biotechnology, sc-53822) was used in western blot on human samples . Cell Mol Life Sci (2016) ncbi
mouse monoclonal (DE2B4)
  • western blot; human; 1:1000; fig 7
Santa Cruz Biotechnology APP antibody (Santa Cruz, DE2B4) was used in western blot on human samples at 1:1000 (fig 7). J Pineal Res (2015) ncbi
mouse monoclonal (DE2B4)
  • western blot; human; 1:500
Santa Cruz Biotechnology APP antibody (Santa Cruz Biotechnology, DE2B4) was used in western blot on human samples at 1:500. J Pineal Res (2015) ncbi
mouse monoclonal (NAB228)
  • immunohistochemistry - paraffin section; human; 1:500
In order to determine the expression of abnormal serine phosphorylation of insulin receptor substrate 1 in healthy and diseased human brains, Santa Cruz Biotechnology APP antibody (Santa Cruz, 3227) was used in immunohistochemistry - paraffin section on human samples at 1:500. Acta Neuropathol (2014) ncbi
Agrisera
mouse monoclonal (IgM)
  • dot blot; mouse; 1:800; loading ...; fig 5a
Agrisera APP antibody (Agrisera, OMAB) was used in dot blot on mouse samples at 1:800 (fig 5a). Int J Mol Sci (2020) ncbi
mouse monoclonal (IgM)
  • western blot; rhesus macaque; 1:1000; loading ...; fig 1d
Agrisera APP antibody (Agrisera, AS10 932) was used in western blot on rhesus macaque samples at 1:1000 (fig 1d). Aging Cell (2019) ncbi
Synaptic Systems
mouse monoclonal (88B12)
  • western blot; mouse; 1:500; loading ...; fig 4a
Synaptic Systems APP antibody (Synaptic Systems, 218711) was used in western blot on mouse samples at 1:500 (fig 4a). Neurobiol Learn Mem (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 2
Synaptic Systems APP antibody (Synaptic Systems, 218703) was used in immunohistochemistry - paraffin section on human samples (fig 2). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (326F12)
  • immunohistochemistry - paraffin section; human; fig 1
Synaptic Systems APP antibody (Synaptic Systems, 218421) was used in immunohistochemistry - paraffin section on human samples (fig 1). Acta Neuropathol Commun (2016) ncbi
MABTECH
mouse monoclonal (bmAbetaN)
  • immunohistochemistry - frozen section; fruit fly ; 1:500; loading ...; fig 3h
MABTECH APP antibody (Mabtech, 3740-5-250) was used in immunohistochemistry - frozen section on fruit fly samples at 1:500 (fig 3h). FEBS Open Bio (2020) ncbi
mouse monoclonal (bmAbetaN)
  • ELISA; human; loading ...; fig 2,4
MABTECH APP antibody (Mabtech, 3740-6-1000) was used in ELISA on human samples (fig 2,4). Biosens Bioelectron (2015) ncbi
Bio-Rad
mouse monoclonal (DE2B4)
  • western blot; human; fig 3b
Bio-Rad APP antibody (AbD Serotec, MCA2172) was used in western blot on human samples (fig 3b). Oncotarget (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D54D2)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 4c
Cell Signaling Technology APP antibody (Cell Signaling Technologies, 8243S) was used in immunohistochemistry on mouse samples at 1:500 (fig 4c). J Biol Chem (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s3e
Cell Signaling Technology APP antibody (Cell Signaling Technology, 2452) was used in western blot on mouse samples (fig s3e). Sci Adv (2021) ncbi
domestic rabbit monoclonal (D54D2)
  • immunohistochemistry - free floating section; mouse; 1:400; loading ...; fig 4e
Cell Signaling Technology APP antibody (Cell Signaling Technology, 8243S) was used in immunohistochemistry - free floating section on mouse samples at 1:400 (fig 4e). Sci Adv (2021) ncbi
domestic rabbit monoclonal (D54D2)
  • western blot; mouse; loading ...; fig 3e
Cell Signaling Technology APP antibody (Cell Signaling, 8243) was used in western blot on mouse samples (fig 3e). Front Cell Neurosci (2020) ncbi
domestic rabbit monoclonal (D54D2)
  • immunohistochemistry - paraffin section; human; 1:2000; loading ...; fig s7b
Cell Signaling Technology APP antibody (Cell Signaling, D54D2) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig s7b). Nature (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:300; loading ...; fig 1a
  • western blot; human; loading ...; fig 1dd-1
Cell Signaling Technology APP antibody (Cell Signaling Technology, 2452S) was used in immunohistochemistry on human samples at 1:300 (fig 1a) and in western blot on human samples (fig 1dd-1). Int J Mol Med (2019) ncbi
domestic rabbit monoclonal (D54D2)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1a
Cell Signaling Technology APP antibody (CELL SIGNALING, 8243s) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1a). Front Neurosci (2019) ncbi
domestic rabbit monoclonal (D54D2)
  • immunohistochemistry; human; 1:500; loading ...
Cell Signaling Technology APP antibody (Cell Signaling Technology, 8243) was used in immunohistochemistry on human samples at 1:500. Nature (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; fig 1c
Cell Signaling Technology APP antibody (Cell Signaling, 2454) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 1c). Nat Neurosci (2019) ncbi
monoclonal (D54D2)
  • immunohistochemistry; mouse; loading ...; fig 7g
Cell Signaling Technology APP antibody (CST, 51374) was used in immunohistochemistry on mouse samples (fig 7g). Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 3e
Cell Signaling Technology APP antibody (Cell Signaling Technology, 2452) was used in western blot on mouse samples (fig 3e). Sci Adv (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 6b
Cell Signaling Technology APP antibody (Cell Signaling Technology, 2452S) was used in western blot on mouse samples (fig 6b). Neurotherapeutics (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; rat; 1:500; loading ...; fig 3e
  • western blot; rat; loading ...; fig 3a
Cell Signaling Technology APP antibody (Cell Signaling, 2454) was used in immunohistochemistry - frozen section on rat samples at 1:500 (fig 3e) and in western blot on rat samples (fig 3a). J Biol Chem (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - free floating section; mouse; 1:250; loading ...; fig 2a
Cell Signaling Technology APP antibody (Cell Signaling, 2454) was used in immunohistochemistry - free floating section on mouse samples at 1:250 (fig 2a). J Neurosci (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:500; loading ...; fig 2a
In order to see that the granulin Alzheimer's disease risk variant has no significant effects on florbetapir positron emission tomographic amyloid imaging and cerebrospinal fluid Abeta levels, Cell Signaling Technology APP antibody (Cell Signaling, 2454) was used in immunohistochemistry on mouse samples at 1:500 (fig 2a). Acta Neuropathol (2017) ncbi
domestic rabbit monoclonal (D90B8)
  • western blot; mouse; loading ...; fig 5
Cell Signaling Technology APP antibody (cell signalling, 6986) was used in western blot on mouse samples (fig 5). Int J Mol Med (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
In order to identify and characterize a DYRK1A inhibitor, Cell Signaling Technology APP antibody (Cell Signaling, 2452) was used in western blot on human samples at 1:1000 (fig 4). Dis Model Mech (2016) ncbi
domestic rabbit monoclonal (D54D2)
  • immunocytochemistry; mouse; 1:250
Cell Signaling Technology APP antibody (Cell Signaling, 8243) was used in immunocytochemistry on mouse samples at 1:250. Acta Neuropathol Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 1
In order to learn about potentiation of behavioral abnormalities, disturbing of iron pathways, and exacerbation of harmaline-induced tremor in mice due to loss of NCB5OR in the cerebellum, Cell Signaling Technology APP antibody (Cell signaling, 2452) was used in western blot on mouse samples (fig 1). Metab Brain Dis (2016) ncbi
domestic rabbit monoclonal (D54D2)
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 4
  • western blot; mouse; 1:4000; fig 4
  • western blot; human; 1:4000; fig 4
Cell Signaling Technology APP antibody (Cell signaling, 8243) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 4), in western blot on mouse samples at 1:4000 (fig 4) and in western blot on human samples at 1:4000 (fig 4). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D2A6H)
  • immunohistochemistry - paraffin section; human; fig 1
Cell Signaling Technology APP antibody (Cell signaling, 12467) was used in immunohistochemistry - paraffin section on human samples (fig 1). Acta Neuropathol Commun (2016) ncbi
domestic rabbit monoclonal (D5Y9L)
  • immunohistochemistry - paraffin section; human; fig 1
Cell Signaling Technology APP antibody (Cell signaling, 12077) was used in immunohistochemistry - paraffin section on human samples (fig 1). Acta Neuropathol Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; tbl 1
In order to study novelty-induced and brain-specific basal alternations in PI3K-Akt and MAPK/ERK signaling in a middle-aged A-betaPP/PS1 mouse model of Alzheimer's disease, Cell Signaling Technology APP antibody (CST, 2452) was used in western blot on mouse samples at 1:1000 (tbl 1). J Alzheimers Dis (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 1
In order to analyze chemogenetic modulation of neural activity by attenuation of beta-amyloid deposition and neurotoxicity, Cell Signaling Technology APP antibody (Cell Signaling, 2454) was used in immunohistochemistry on mouse samples (fig 1). J Neurosci (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:250; fig s9
In order to study the coupling of cellular prion protein to intracellular signaling in Alzheimer's disease by metabotropic glutamate receptor 5, Cell Signaling Technology APP antibody (Cell Signalling, 2454) was used in immunohistochemistry on mouse samples at 1:250 (fig s9). Brain (2016) ncbi
domestic rabbit monoclonal (D54D2)
  • western blot; mouse; 1:1000
Cell Signaling Technology APP antibody (Cell Signaling, 8243) was used in western blot on mouse samples at 1:1000. Proc Natl Acad Sci U S A (2015) ncbi
domestic rabbit monoclonal (D54D2)
  • western blot; human; 1:200; fig 7
In order to determine the role of PICALM in Abeta transcytosis across the blood brain barrier, Cell Signaling Technology APP antibody (Cell Signaling Technology, 8243) was used in western blot on human samples at 1:200 (fig 7). Nat Neurosci (2015) ncbi
domestic rabbit monoclonal (D54D2)
  • western blot; human; 1:1000
In order to assess the effect of carnosic acid on apoptosis induced by Abeta42 or Abeta43 in human neuroblastoma cells, Cell Signaling Technology APP antibody (Cell Signaling, #8243) was used in western blot on human samples at 1:1000. Neurosci Res (2015) ncbi
domestic rabbit monoclonal (D2A6H)
  • ELISA; human
  • western blot; human
In order to discuss the effects of BMS-869780, a gamma secretase inhibitor, in several animal models, Cell Signaling Technology APP antibody (Cell Signaling, 12356BF) was used in ELISA on human samples and in western blot on human samples . Int J Alzheimers Dis (2014) ncbi
Dako
mouse monoclonal (6F/3D)
  • immunohistochemistry; human; 1:1000; loading ...; fig 1f
Dako APP antibody (DAKO, 6F/3D) was used in immunohistochemistry on human samples at 1:1000 (fig 1f). J Clin Med (2020) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:2000; loading ...; fig 2a
Dako APP antibody (Dako, M0872) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 2a). Aging (Albany NY) (2020) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry; human; 1:50; loading ...; tbl 2
Dako APP antibody (Dako, 6F/3D) was used in immunohistochemistry on human samples at 1:50 (tbl 2). Neurology (2020) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1a
Dako APP antibody (Dako-Agilent, M0872) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1a). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; mouse; 1:200
  • immunohistochemistry; mouse; loading ...; fig 16
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako APP antibody (Dako, M0872) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 and in immunohistochemistry on mouse samples (fig 16). J Toxicol Pathol (2017) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...
In order to examine the mutation spectrum of the TANK-Binding Kinase 1 gene and its associated phenotypic spectrum in patients with FTD, ALS or FTD plus ALS, Dako APP antibody (DAKO, 6F/3D) was used in immunohistochemistry - paraffin section on human samples at 1:400. Hum Mutat (2017) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1a
In order to test if ROCK1 governs the metabolism of amyloid precursor protein, Dako APP antibody (Dako, M0872) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1a). Front Cell Neurosci (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; loading ...
Dako APP antibody (Dako, 6F/3D) was used in immunohistochemistry - paraffin section on human samples . Am J Hum Genet (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 3
In order to characterize an Alzheimer's disease model that utilizes Octodon degus, Dako APP antibody (Dako, M0872) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 3). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; tbl 2
Dako APP antibody (DakoCytomation, 6F/3D) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Alzheimers Res Ther (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...
In order to detail the neuropathological features of the anti-IgLON5 syndrome in order to diagnose patients, Dako APP antibody (DAKO, 6F/3D) was used in immunohistochemistry - paraffin section on human samples at 1:400. Acta Neuropathol (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:50; fig 7
In order to characterize the cerebral cortex during the progression of Alzheimer disease pathology by visualizing subcellular changes in bridging integrator 1 protein expression, Dako APP antibody (Dako, M0872) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 7). J Neuropathol Exp Neurol (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry; mouse; 1:100; fig 4
In order to study the attenuation of Alzheimer's pathology in mice due to kallikrein-8 inhibition, Dako APP antibody (DAKO, 6F/3D) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). Alzheimers Dement (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry; mouse; 1:100; fig 2
In order to assess the impairment in synaptic plasticity and learning due to amyloid-beta dimers in the absence of plaque pathology, Dako APP antibody (Dako, M0872) was used in immunohistochemistry on mouse samples at 1:100 (fig 2). Brain (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:100
In order to present data from the first donated Lothian Birth Cohort of 1936 and compare it with other aged and diseased samples, Dako APP antibody (Dako, M087201-2) was used in immunohistochemistry - paraffin section on human samples at 1:100. Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry; human; tbl 1
In order to characterize the neuropathologic evaluation of Alzheimer's disease by multisite assessment of NIA-AA guidelines, Dako APP antibody (Dako, 6F/3D) was used in immunohistochemistry on human samples (tbl 1). Alzheimers Dement (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry; human; 1:50; loading ...; fig 2
Dako APP antibody (Dako, 6F/3D) was used in immunohistochemistry on human samples at 1:50 (fig 2). Neuropathology (2016) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to investigate how microglia and iron contribute to Alzheimer's disease, Dako APP antibody (Dako, M0872) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Neurobiol Aging (2015) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry; human; 1:400; fig s1
In order to report the neuropathologic autopsy findings of a man with the rare Tyr69His transthyretin gene variant, Dako APP antibody (Dako, M0872) was used in immunohistochemistry on human samples at 1:400 (fig s1). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:50
In order to study neuroinflammation-related gene regulation during normal aging and in sporadic Alzheimer disease in mice, Dako APP antibody (Dako, 6 F/3D) was used in immunohistochemistry - paraffin section on human samples at 1:50. J Neuropathol Exp Neurol (2015) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:500
In order to evaluate the role of DNA content in Lewy body diseases, Dako APP antibody (Dako, M0872) was used in immunohistochemistry - paraffin section on human samples at 1:500. Neurobiol Aging (2015) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - free floating section; mouse; 1:100
In order to investigate the abnormalites in hippocampal energy metabolism in the pathogenesis of Alzheimer disease, Dako APP antibody (DakoCytomation, 6F/3D) was used in immunohistochemistry - free floating section on mouse samples at 1:100. Biochim Biophys Acta (2014) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry; human; 1:100
Dako APP antibody (Dako, M0872) was used in immunohistochemistry on human samples at 1:100. Neurobiol Aging (2014) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - paraffin section; human; 1:200
Dako APP antibody (DAKO, 6F/3D) was used in immunohistochemistry - paraffin section on human samples at 1:200. Glia (2013) ncbi
mouse monoclonal (6F/3D)
Dako APP antibody (DAKO, M0872) was used . Exp Neurol (2009) ncbi
mouse monoclonal (6F/3D)
  • immunohistochemistry - free floating section; human; 1:50
Dako APP antibody (Dako, 6F/3D) was used in immunohistochemistry - free floating section on human samples at 1:50. Brain Res (2001) ncbi
Alpha Diagnostics
domestic rabbit
  • immunohistochemistry - paraffin section; rat; 1:200
Alpha Diagnostics APP antibody (Alpha Diagnostic International, BAM421-A) was used in immunohistochemistry - paraffin section on rat samples at 1:200. Fluids Barriers CNS (2015) ncbi
domestic rabbit
  • immunohistochemistry - paraffin section; rat; 1:100
Alpha Diagnostics APP antibody (Alpha Diagnostic International, BAM401-A) was used in immunohistochemistry - paraffin section on rat samples at 1:100. Fluids Barriers CNS (2015) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot; mouse; loading ...
MilliporeSigma APP antibody (Sigma, A3356) was used in western blot on mouse samples . Cell Death Discov (2020) ncbi
mouse monoclonal (BAM-10)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 4a
MilliporeSigma APP antibody (Sigma-Aldrich, A5213) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 4a). J Neuroinflammation (2020) ncbi
mouse monoclonal (BAM-10)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2d
MilliporeSigma APP antibody (Sigma, A5213) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2d). Int J Mol Sci (2017) ncbi
mouse monoclonal (BAM-10)
  • immunohistochemistry; mouse; loading ...; fig 4
MilliporeSigma APP antibody (Sigma, A5213) was used in immunohistochemistry on mouse samples (fig 4). Int J Mol Med (2017) ncbi
mouse monoclonal (NAB 228)
  • ELISA; human; loading ...; fig 2,4
MilliporeSigma APP antibody (Sigma, A8354) was used in ELISA on human samples (fig 2,4). Biosens Bioelectron (2015) ncbi
mouse monoclonal (NAB 228)
  • ELISA; mouse; loading ...; fig s1
MilliporeSigma APP antibody (Sigma-Aldrich, A8354) was used in ELISA on mouse samples (fig s1). PLoS ONE (2014) ncbi
mouse monoclonal (BAM-10)
  • ELISA; mouse; loading ...; fig s1
MilliporeSigma APP antibody (Sigma-Aldrich, A3981) was used in ELISA on mouse samples (fig s1). PLoS ONE (2014) ncbi
mouse monoclonal (NAB 228)
  • western blot; human; loading ...; fig 7c
MilliporeSigma APP antibody (Sigma-Aldrich, A8354) was used in western blot on human samples (fig 7c). Mol Cell Neurosci (2014) ncbi
Leica Biosystems
(6F/3D)
  • immunohistochemistry; human; 1:200; fig 1
Leica Biosystems APP antibody (Novocastra, 6F-3D) was used in immunohistochemistry on human samples at 1:200 (fig 1). Acta Neuropathol Commun (2021) ncbi
(6F/3D)
  • immunohistochemistry; human; 1:50; loading ...; tbl 1
In order to analyze autopsied corpses and reveal that progressive supranuclear palsy may be more common than previously thought, Leica Biosystems APP antibody (Novocastra Vector Labs, 6F/3D) was used in immunohistochemistry on human samples at 1:50 (tbl 1). Acta Neuropathol (2017) ncbi
(6F/3D)
  • western blot; human; loading ...; fig 5
In order to examine postmortem brain tissues from five institutionalized patients with schizophrenia and history of surgical leucotomy with subsequent survival of at least another 40 years, Leica Biosystems APP antibody (Leica Biosystems, 6F/3D) was used in western blot on human samples (fig 5). Acta Neuropathol (2017) ncbi
Biosensis
mouse monoclonal
  • immunohistochemistry - frozen section; mouse; 1:1000; fig 3
Biosensis APP antibody (Biosensis, M-1586-100) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 3). Front Neurosci (2016) ncbi
mouse monoclonal
  • immunohistochemistry; mouse; fig s2
In order to investigate the relationship between beta-amyloid plaques and microglia, Biosensis APP antibody (Biosensis, M-1586-100) was used in immunohistochemistry on mouse samples (fig s2). Nat Commun (2015) ncbi
Articles Reviewed
  1. Sil S, Singh S, Chemparathy D, Chivero E, Gordon L, Buch S. Astrocytes & Astrocyte derived Extracellular Vesicles in Morphine Induced Amyloidopathy: Implications for Cognitive Deficits in Opiate Abusers. Aging Dis. 2021;12:1389-1408 pubmed publisher
  2. Nies S, Takahashi H, Herber C, Huttner A, Chase A, Strittmatter S. Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β. J Biol Chem. 2021;297:101159 pubmed publisher
  3. Villanueva E, Tresse E, Liu Y, Duarte J, Jimenez Duran G, Ejlerskov P, et al. Neuronal TNFα, Not α-Syn, Underlies PDD-Like Disease Progression in IFNβ-KO Mice. Ann Neurol. 2021;90:789-807 pubmed publisher
  4. Luo R, Fan Y, Yang J, Ye M, Zhang D, Guo K, et al. A novel missense variant in ACAA1 contributes to early-onset Alzheimer's disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline. Signal Transduct Target Ther. 2021;6:325 pubmed publisher
  5. Lee S, Chen Y, Chien C, Yan Y, Chen H, Chuang H, et al. Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer's disease mouse model. PLoS ONE. 2021;16:e0254587 pubmed publisher
  6. Cheng J, Dong Y, Ma J, Pan R, Liao Y, Kong X, et al. Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer's disease pathology. Sci Adv. 2021;7: pubmed publisher
  7. d Uscio L, Katusic Z. Endothelium-specific deletion of amyloid-β precursor protein exacerbates endothelial dysfunction induced by aging. Aging (Albany NY). 2021;13:19165-19185 pubmed publisher
  8. Jeong A, Cheng S, Zhong R, Bennett D, Bergo M, Li L. Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice. Acta Neuropathol Commun. 2021;9:129 pubmed publisher
  9. Xu X, Sun Y, Cen X, Shan B, Zhao Q, Xie T, et al. Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model. Protein Cell. 2021;: pubmed publisher
  10. Emre C, Do K, Jun B, Hjorth E, Alcalde S, Kautzmann M, et al. Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2021;9:116 pubmed publisher
  11. Sha S, Shen X, Cao Y, Qu L. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway. Aging (Albany NY). 2021;13:15285-15306 pubmed publisher
  12. Zhang J, Wu N, Wang S, Yao Z, Xiao F, Lu J, et al. Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer's disease. Aging Cell. 2021;20:e13380 pubmed publisher
  13. Doré K, Carrico Z, Alfonso S, Marino M, Koymans K, Kessels H, et al. PSD-95 protects synapses from β-amyloid. Cell Rep. 2021;35:109194 pubmed publisher
  14. Zhang H, Li J, Ren J, Sun S, Ma S, Zhang W, et al. Single-nucleus transcriptomic landscape of primate hippocampal aging. Protein Cell. 2021;12:695-716 pubmed publisher
  15. Dá Mesquita S, Herz J, Wall M, Dykstra T, de Lima K, Norris G, et al. Aging-associated deficit in CCR7 is linked to worsened glymphatic function, cognition, neuroinflammation, and β-amyloid pathology. Sci Adv. 2021;7: pubmed publisher
  16. Tournissac M, Vu T, Vrabic N, Hozer C, Tremblay C, Mélançon K, et al. Repurposing beta-3 adrenergic receptor agonists for Alzheimer's disease: beneficial effects in a mouse model. Alzheimers Res Ther. 2021;13:103 pubmed publisher
  17. Bradshaw D, Knutsen A, Korotcov A, Sullivan G, Radomski K, Dardzinski B, et al. Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures. Acta Neuropathol Commun. 2021;9:89 pubmed publisher
  18. Park J, Kam T, Lee S, Park H, Oh Y, Kwon S, et al. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease. Acta Neuropathol Commun. 2021;9:78 pubmed publisher
  19. Huang Y, Happonen K, Burrola P, O Connor C, Hah N, Huang L, et al. Microglia use TAM receptors to detect and engulf amyloid β plaques. Nat Immunol. 2021;22:586-594 pubmed publisher
  20. Martinez Valbuena I, Valenti Azcarate R, Amat Villegas I, Marcilla I, Martí Andrés G, Caballero M, et al. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein. Acta Neuropathol Commun. 2021;9:64 pubmed publisher
  21. Miguel J, Perez S, Malek Ahmadi M, Mufson E. Cerebellar Calcium-Binding Protein and Neurotrophin Receptor Defects in Down Syndrome and Alzheimer's Disease. Front Aging Neurosci. 2021;13:645334 pubmed publisher
  22. Hanna R, Flamier A, Barabino A, Bernier G. G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer's disease. Nat Commun. 2021;12:1828 pubmed publisher
  23. Reyes J, Ekmark Lewén S, Perdiki M, Klingstedt T, Hoffmann A, Wiechec E, et al. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease. Acta Neuropathol Commun. 2021;9:46 pubmed publisher
  24. Vandenabeele M, Veys L, Lemmens S, Hadoux X, Gelders G, Masin L, et al. The AppNL-G-F mouse retina is a site for preclinical Alzheimer's disease diagnosis and research. Acta Neuropathol Commun. 2021;9:6 pubmed publisher
  25. Zhang X, Gou Y, Zhang Y, Li J, Han K, Xu Y, et al. Hepcidin overexpression in astrocytes alters brain iron metabolism and protects against amyloid-β induced brain damage in mice. Cell Death Discov. 2020;6:113 pubmed publisher
  26. Hashimoto T, Fujii D, Naka Y, Kashiwagi Hakozaki M, Matsuo Y, Matsuura Y, et al. Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques. Acta Neuropathol Commun. 2020;8:212 pubmed publisher
  27. Zhang X, Wang R, Hu D, Sun X, Fujioka H, Lundberg K, et al. Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer's disease. Sci Adv. 2020;6: pubmed publisher
  28. Gonzalo Gobernado R, Perucho J, Vallejo Muñoz M, Casarejos M, Reimers D, Jimenez Escrig A, et al. Liver Growth Factor "LGF" as a Therapeutic Agent for Alzheimer's Disease. Int J Mol Sci. 2020;21: pubmed publisher
  29. Lin L, Petralia R, Lake R, Wang Y, Hoffman D. A novel structure associated with aging is augmented in the DPP6-KO mouse brain. Acta Neuropathol Commun. 2020;8:197 pubmed publisher
  30. Iyaswamy A, Krishnamoorthi S, Liu Y, Song J, Kammala A, Sreenivasmurthy S, et al. Yuan-Hu Zhi Tong Prescription Mitigates Tau Pathology and Alleviates Memory Deficiency in the Preclinical Models of Alzheimer's Disease. Front Pharmacol. 2020;11:584770 pubmed publisher
  31. Lackie R, Marques Lopes J, Ostapchenko V, Good S, Choy W, van Oosten Hawle P, et al. Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2020;8:143 pubmed publisher
  32. Ikonomovic M, Buckley C, Abrahamson E, Kofler J, Mathis C, Klunk W, et al. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease. Acta Neuropathol. 2020;140:463-476 pubmed publisher
  33. Kazuki Y, Gao F, Li Y, Moyer A, Devenney B, Hiramatsu K, et al. A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21. elife. 2020;9: pubmed publisher
  34. Wander C, Tseng J, Song S, Al Housseiny H, Tart D, Ajit A, et al. The Accumulation of Tau-Immunoreactive Hippocampal Granules and Corpora Amylacea Implicates Reactive Glia in Tau Pathogenesis during Aging. iScience. 2020;23:101255 pubmed publisher
  35. Sebastian Monasor L, Müller S, Colombo A, Tanrioever G, König J, Roth S, et al. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. elife. 2020;9: pubmed publisher
  36. Ren P, Chen J, Li B, Zhang M, Yang B, Guo X, et al. Nrf2 Ablation Promotes Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress. Oxid Med Cell Longev. 2020;2020:3050971 pubmed publisher
  37. Yilmazer Hanke D, Mayer T, Müller H, Neugebauer H, Abaei A, Scheuerle A, et al. Histological correlates of postmortem ultra-high-resolution single-section MRI in cortical cerebral microinfarcts. Acta Neuropathol Commun. 2020;8:33 pubmed publisher
  38. Lloyd G, Trejo Lopez J, Xia Y, McFarland K, Lincoln S, Ertekin Taner N, et al. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease. Acta Neuropathol Commun. 2020;8:31 pubmed publisher
  39. Pilozzi A, Yu Z, Carreras I, Cormier K, Hartley D, Rogers J, et al. A Preliminary Study of Cu Exposure Effects upon Alzheimer's Amyloid Pathology. Biomolecules. 2020;10: pubmed publisher
  40. Huang Z, Zhao J, Wang W, Zhou J, Zhang J. Depletion of LncRNA NEAT1 Rescues Mitochondrial Dysfunction Through NEDD4L-Dependent PINK1 Degradation in Animal Models of Alzheimer's Disease. Front Cell Neurosci. 2020;14:28 pubmed publisher
  41. Honarpisheh P, Reynolds C, Blasco Conesa M, Moruno Manchon J, Putluri N, Bhattacharjee M, et al. Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice. Int J Mol Sci. 2020;21: pubmed publisher
  42. Tang Y, Xu A, Shao S, Zhou Y, Xiong B, Li Z. Electroacupuncture Ameliorates Cognitive Impairment by Inhibiting the JNK Signaling Pathway in a Mouse Model of Alzheimer's Disease. Front Aging Neurosci. 2020;12:23 pubmed publisher
  43. Rodriguez Ortiz C, Prieto G, Martini A, Forner S, Trujillo Estrada L, LaFerla F, et al. miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease. Aging Cell. 2020;19:e13118 pubmed publisher
  44. Yang Y, He Z, Xing Z, Zuo Z, Yuan L, Wu Y, et al. Influenza vaccination in early Alzheimer's disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells. J Neuroinflammation. 2020;17:65 pubmed publisher
  45. Barros Viegas A, Carmona V, Ferreiro E, Guedes J, Cardoso A, Cunha P, et al. miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer's Disease. Mol Ther Nucleic Acids. 2020;19:1219-1236 pubmed publisher
  46. Moreno Rodríguez M, Perez S, Nadeem M, Malek Ahmadi M, Mufson E. Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease. J Neuroinflammation. 2020;17:58 pubmed publisher
  47. Shi H, Koronyo Y, Rentsendorj A, Regis G, Sheyn J, Fuchs D, et al. Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina. Acta Neuropathol. 2020;139:813-836 pubmed publisher
  48. Tambini M, Norris K, D ADAMIO L. Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation. elife. 2020;9: pubmed publisher
  49. Lundgren J, Vandermeulen L, Sandebring Matton A, Ahmed S, Winblad B, Di Luca M, et al. Proximity ligation assay reveals both pre- and postsynaptic localization of the APP-processing enzymes ADAM10 and BACE1 in rat and human adult brain. BMC Neurosci. 2020;21:6 pubmed publisher
  50. McGeer P, Lee M, Kennedy K, McGeer E. Saliva Diagnosis as a Disease Predictor. J Clin Med. 2020;9: pubmed publisher
  51. Eede P, Obst J, Benke E, Yvon Durocher G, Richard B, Gimber N, et al. Interleukin-12/23 deficiency differentially affects pathology in male and female Alzheimer's disease-like mice. EMBO Rep. 2020;21:e48530 pubmed publisher
  52. Oh S, Kim J, Park S, Lee J. Associative Interactions among Zinc, Apolipoprotein E, and Amyloid-β in the Amyloid Pathology. Int J Mol Sci. 2020;21: pubmed publisher
  53. Meilandt W, Ngu H, Gogineni A, Lalehzadeh G, Lee S, Srinivasan K, et al. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model. J Neurosci. 2020;40:1956-1974 pubmed publisher
  54. Walker D, Tang T, Mendsaikhan A, Tooyama I, Serrano G, Sue L, et al. Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains. Int J Mol Sci. 2020;21: pubmed publisher
  55. Yan T, Liang J, Gao J, Wang L, Fujioka H, Zhu X, et al. FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease. Nat Commun. 2020;11:411 pubmed publisher
  56. Li J, Chiu J, Ramanjulu M, Blass B, Pratico D. A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles. Mol Neurodegener. 2020;15:1 pubmed publisher
  57. Evonuk K, Doyle R, Moseley C, Thornell I, Adler K, Bingaman A, et al. Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation. Sci Adv. 2020;6:eaax5936 pubmed publisher
  58. Pi G, Gao D, Wu D, Wang Y, Lei H, Zeng W, et al. Posterior basolateral amygdala to ventral hippocampal CA1 drives approach behaviour to exert an anxiolytic effect. Nat Commun. 2020;11:183 pubmed publisher
  59. El Gaamouch F, Audrain M, Lin W, Beckmann N, Jiang C, Hariharan S, et al. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice. Mol Neurodegener. 2020;15:4 pubmed publisher
  60. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  61. Rice H, Marcassa G, Chrysidou I, Horré K, Young Pearse T, Müller U, et al. Contribution of GABAergic interneurons to amyloid-β plaque pathology in an APP knock-in mouse model. Mol Neurodegener. 2020;15:3 pubmed publisher
  62. Braak H, Del Tredici K. From the Entorhinal Region via the Prosubiculum to the Dentate Fascia: Alzheimer Disease-Related Neurofibrillary Changes in the Temporal Allocortex. J Neuropathol Exp Neurol. 2020;79:163-175 pubmed publisher
  63. Bhattarai P, Cosacak M, Mashkaryan V, Demir S, Popova S, Govindarajan N, et al. Neuron-glia interaction through Serotonin-BDNF-NGFR axis enables regenerative neurogenesis in Alzheimer's model of adult zebrafish brain. PLoS Biol. 2020;18:e3000585 pubmed publisher
  64. Smith R, Pawlik D, Nilsson C, Englund E, Hansson O. [18F]Flortaucipir distinguishes Alzheimer's disease from progressive supranuclear palsy pathology in a mixed-pathology case. Acta Neuropathol. 2020;139:411-413 pubmed publisher
  65. Arenas F, Castro F, Núñez S, Gay G, Garcia Ruiz C, Fernandez Checa J. STARD1 and NPC1 expression as pathological markers associated with astrogliosis in post-mortem brains from patients with Alzheimer's disease and Down syndrome. Aging (Albany NY). 2020;12:571-592 pubmed publisher
  66. Bergkvist L, Du Z, Elovsson G, Appelqvist H, Itzhaki L, Kumita J, et al. Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease. FEBS Open Bio. 2020;10:338-350 pubmed publisher
  67. Pires G, McElligott S, Drusinsky S, Halliday G, Potier M, Wisniewski T, et al. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies. Acta Neuropathol Commun. 2019;7:195 pubmed publisher
  68. Ghatak S, Dolatabadi N, Trudler D, Zhang X, Wu Y, Mohata M, et al. Mechanisms of hyperexcitability in Alzheimer's disease hiPSC-derived neurons and cerebral organoids vs isogenic controls. elife. 2019;8: pubmed publisher
  69. Yu L, Boyle P, Dawe R, Bennett D, Arfanakis K, Schneider J. Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology. 2020;94:e142-e152 pubmed publisher
  70. Wu X, Chen S, Lu C. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway. Int J Mol Med. 2019;: pubmed publisher
  71. Hansson O, Svensson M, Gustavsson A, Andersson E, Yang Y, Nagga K, et al. Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease. Alzheimers Res Ther. 2019;11:87 pubmed publisher
  72. Newell E, Todd B, Luo Z, Evans L, Ferguson P, Bassuk A. A Mouse Model for Juvenile, Lateral Fluid Percussion Brain Injury Reveals Sex-Dependent Differences in Neuroinflammation and Functional Recovery. J Neurotrauma. 2020;37:635-646 pubmed publisher
  73. Grimaldi A, Pediconi N, Oieni F, Pizzarelli R, Rosito M, Giubettini M, et al. Neuroinflammatory Processes, A1 Astrocyte Activation and Protein Aggregation in the Retina of Alzheimer's Disease Patients, Possible Biomarkers for Early Diagnosis. Front Neurosci. 2019;13:925 pubmed publisher
  74. Wang Z, Xiang J, Liu X, Yu S, Manfredsson F, Sandoval I, et al. Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease. Cell Rep. 2019;28:655-669.e5 pubmed publisher
  75. Latimer C, Burke B, Liachko N, Currey H, Kilgore M, Gibbons L, et al. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort. Acta Neuropathol Commun. 2019;7:9 pubmed publisher
  76. Zhang J, Chen B, Lu J, Wu Y, Wang S, Yao Z, et al. Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer's pathologies. Aging Cell. 2019;18:e12978 pubmed publisher
  77. Libard S, Alafuzoff I. Alzheimer's disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer's disease. Acta Neuropathol Commun. 2019;7:3 pubmed publisher
  78. Mathys H, Davila Velderrain J, Peng Z, Gao F, Mohammadi S, Young J, et al. Single-cell transcriptomic analysis of Alzheimer's disease. Nature. 2019;570:332-337 pubmed publisher
  79. Adeosun S, Hou X, Shi L, Stockmeier C, Zheng B, Raffai R, et al. Female mice with apolipoprotein E4 domain interaction demonstrated impairments in spatial learning and memory performance and disruption of hippocampal cyto-architecture. Neurobiol Learn Mem. 2019;161:106-114 pubmed publisher
  80. Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler R, Zhang S, et al. Senolytic therapy alleviates Aβ-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer's disease model. Nat Neurosci. 2019;22:719-728 pubmed publisher
  81. Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model. Nat Commun. 2019;10:1365 pubmed publisher
  82. Martorell A, Paulson A, Suk H, Abdurrob F, Drummond G, Guan W, et al. Multi-sensory Gamma Stimulation Ameliorates Alzheimer's-Associated Pathology and Improves Cognition. Cell. 2019;177:256-271.e22 pubmed publisher
  83. Mammone T, Chidlow G, Casson R, Wood J. Improved immunohistochemical detection of phosphorylated mitogen-activated protein kinases in the injured rat optic nerve head. Histochem Cell Biol. 2019;151:435-456 pubmed publisher
  84. Pan R, Ma J, Kong X, Wang X, Li S, Qi X, et al. Sodium rutin ameliorates Alzheimer's disease-like pathology by enhancing microglial amyloid-β clearance. Sci Adv. 2019;5:eaau6328 pubmed publisher
  85. Michno W, Nyström S, Wehrli P, Lashley T, Brinkmalm G, Guerard L, et al. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology. J Biol Chem. 2019;294:6719-6732 pubmed publisher
  86. Sri S, Pegasiou C, Cave C, Hough K, Wood N, Gomez Nicola D, et al. Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2019;7:25 pubmed publisher
  87. Lahiri S, Regis G, Koronyo Y, Fuchs D, Sheyn J, Kim E, et al. Acute neuropathological consequences of short-term mechanical ventilation in wild-type and Alzheimer's disease mice. Crit Care. 2019;23:63 pubmed publisher
  88. Dominy S, LYNCH C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5:eaau3333 pubmed publisher
  89. Gutierrez Mecinas M, Bell A, Shepherd F, Polgár E, Watanabe M, Furuta T, et al. Expression of cholecystokinin by neurons in mouse spinal dorsal horn. J Comp Neurol. 2019;527:1857-1871 pubmed publisher
  90. Pierzynowska K, Podlacha M, Gaffke L, Majkutewicz I, Mantej J, Wegrzyn A, et al. Autophagy-dependent mechanism of genistein-mediated elimination of behavioral and biochemical defects in the rat model of sporadic Alzheimer's disease. Neuropharmacology. 2019;148:332-346 pubmed publisher
  91. Gerber H, Mosser S, Boury Jamot B, Stumpe M, Piersigilli A, Goepfert C, et al. The APMAP interactome reveals new modulators of APP processing and beta-amyloid production that are altered in Alzheimer's disease. Acta Neuropathol Commun. 2019;7:13 pubmed publisher
  92. Rosenzweig N, Dvir Szternfeld R, Tsitsou Kampeli A, Keren Shaul H, Ben Yehuda H, Weill Raynal P, et al. PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. Nat Commun. 2019;10:465 pubmed publisher
  93. Beckelman B, Yang W, Kasica N, Zimmermann H, Zhou X, Keene C, et al. Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice. J Clin Invest. 2019;129:820-833 pubmed publisher
  94. Reichenbach N, Delekate A, Plescher M, Schmitt F, Krauss S, Blank N, et al. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer's disease model. EMBO Mol Med. 2019;11: pubmed publisher
  95. Sun J, Carlson Stevermer J, Das U, Shen M, Delenclos M, Snead A, et al. CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage. Nat Commun. 2019;10:53 pubmed publisher
  96. Tan J, Gleeson P. The trans-Golgi network is a major site for α-secretase processing of amyloid precursor protein in primary neurons. J Biol Chem. 2019;294:1618-1631 pubmed publisher
  97. Thygesen C, Ilkjær L, Kempf S, Hemdrup A, von Linstow C, Babcock A, et al. Diverse Protein Profiles in CNS Myeloid Cells and CNS Tissue From Lipopolysaccharide- and Vehicle-Injected APPSWE/PS1ΔE9 Transgenic Mice Implicate Cathepsin Z in Alzheimer's Disease. Front Cell Neurosci. 2018;12:397 pubmed publisher
  98. Real R, Peter M, Trabalza A, Khan S, Smith M, Dopp J, et al. In vivo modeling of human neuron dynamics and Down syndrome. Science. 2018;362: pubmed publisher
  99. Ou Yang M, Kurz J, Nomura T, Popovic J, Rajapaksha T, Dong H, et al. Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice. Sci Transl Med. 2018;10: pubmed publisher
  100. Götzl J, Colombo A, Fellerer K, Reifschneider A, Werner G, Tahirovic S, et al. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice. Mol Neurodegener. 2018;13:48 pubmed publisher
  101. Liu D, Lu H, Stein E, Zhou Z, Yang Y, Mattson M. Brain regional synchronous activity predicts tauopathy in 3×TgAD mice. Neurobiol Aging. 2018;70:160-169 pubmed publisher
  102. Hartl D, May P, Gu W, Mayhaus M, Pichler S, Spaniol C, et al. A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease. Mol Psychiatry. 2018;: pubmed publisher
  103. Baglietto Vargas D, Prieto G, Limon A, Forner S, Rodriguez Ortiz C, Ikemura K, et al. Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease. Aging Cell. 2018;17:e12791 pubmed publisher
  104. Barbero Camps E, Roca Agujetas V, Bartolessis I, de Dios C, Fernandez Checa J, Mari M, et al. Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion. Autophagy. 2018;14:1129-1154 pubmed publisher
  105. Ziegler Waldkirch S, Marksteiner K, Stoll J, d Errico P, Friesen M, Eiler D, et al. Environmental enrichment reverses Aβ pathology during pregnancy in a mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2018;6:44 pubmed publisher
  106. Huang M, Qi W, Fang S, Jiang P, Yang C, Mo Y, et al. Pigment Epithelium-Derived Factor Plays a Role in Alzheimer's Disease by Negatively Regulating Aβ42. Neurotherapeutics. 2018;15:728-741 pubmed publisher
  107. Reichenbach N, Delekate A, Breithausen B, Keppler K, Poll S, Schulte T, et al. P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer's disease model. J Exp Med. 2018;215:1649-1663 pubmed publisher
  108. Wendeln A, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018;556:332-338 pubmed publisher
  109. Wang C, Najm R, Xu Q, Jeong D, Walker D, Balestra M, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018;24:647-657 pubmed publisher
  110. Chiang A, Fowler S, Savjani R, Hilsenbeck S, Wallace C, Cirrito J, et al. Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. J Exp Med. 2018;215:1349-1364 pubmed publisher
  111. Casali B, Reed Geaghan E, Landreth G. Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease. J Neuroinflammation. 2018;15:43 pubmed publisher
  112. Hu X, Das B, Hou H, He W, Yan R. BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions. J Exp Med. 2018;215:927-940 pubmed publisher
  113. Hou Y, Lautrup S, Cordonnier S, Wang Y, Croteau D, Zavala E, et al. NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci U S A. 2018;115:E1876-E1885 pubmed publisher
  114. Mukadam A, Breusegem S, Seaman M. Analysis of novel endosome-to-Golgi retrieval genes reveals a role for PLD3 in regulating endosomal protein sorting and amyloid precursor protein processing. Cell Mol Life Sci. 2018;75:2613-2625 pubmed publisher
  115. Cramer P, Gentzel R, Tanis K, Vardigan J, Wang Y, Connolly B, et al. Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease. Neurobiol Aging. 2018;64:92-106 pubmed publisher
  116. Chiang A, Fowler S, Reddy R, Pletnikova O, Troncoso J, Sherman M, et al. Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis. Am J Pathol. 2018;188:739-756 pubmed publisher
  117. Ziegler Waldkirch S, d Errico P, Sauer J, Erny D, Savanthrapadian S, Loreth D, et al. Seed-induced Aβ deposition is modulated by microglia under environmental enrichment in a mouse model of Alzheimer's disease. EMBO J. 2018;37:167-182 pubmed publisher
  118. Benvegnù S, Wahle T, Dotti C. E3 ligase mahogunin (MGRN1) influences amyloid precursor protein maturation and secretion. Oncotarget. 2017;8:89439-89450 pubmed publisher
  119. Gasparotto J, Girardi C, Somensi N, Ribeiro C, Moreira J, Michels M, et al. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment. J Biol Chem. 2018;293:226-244 pubmed publisher
  120. Ruan C, Liu J, Yang M, Saadipour K, Zeng Y, Liao H, et al. Sortilin inhibits amyloid pathology by regulating non-specific degradation of APP. Exp Neurol. 2018;299:75-85 pubmed publisher
  121. Íñigo Marco I, Valencia M, Larrea L, Bugallo R, Martínez Goikoetxea M, Zuriguel I, et al. E46K ?-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation. Proc Natl Acad Sci U S A. 2017;114:E8274-E8283 pubmed publisher
  122. Edler M, Sherwood C, Meindl R, Hopkins W, Ely J, Erwin J, et al. Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease. Neurobiol Aging. 2017;59:107-120 pubmed publisher
  123. Tseng J, Xie L, Song S, Xie Y, Allen L, Ajit D, et al. The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology. Cell Rep. 2017;20:2169-2183 pubmed publisher
  124. Salazar S, Gallardo C, Kaufman A, Herber C, Haas L, Robinson S, et al. Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease. J Neurosci. 2017;37:9207-9221 pubmed publisher
  125. Rocchi A, Yamamoto S, Ting T, Fan Y, SADLEIR K, Wang Y, et al. A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer's disease. PLoS Genet. 2017;13:e1006962 pubmed publisher
  126. Bustos V, Pulina M, Kelahmetoglu Y, Sinha S, Gorelick F, Flajolet M, et al. Bidirectional regulation of Aβ levels by Presenilin 1. Proc Natl Acad Sci U S A. 2017;114:7142-7147 pubmed publisher
  127. Siedlak S, Jiang Y, Huntley M, Wang L, Gao J, Xie F, et al. TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease. J Alzheimers Dis. 2017;58:1027-1033 pubmed publisher
  128. Li J, Barrero C, Merali S, Pratico D. Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer's phenotype. Sci Rep. 2017;7:46002 pubmed publisher
  129. Latina V, Caioli S, Zona C, Ciotti M, Amadoro G, Calissano P. Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons. Front Cell Neurosci. 2017;11:68 pubmed publisher
  130. Poulsen E, Iannuzzi F, Rasmussen H, Maier T, Enghild J, Jørgensen A, et al. An Aberrant Phosphorylation of Amyloid Precursor Protein Tyrosine Regulates Its Trafficking and the Binding to the Clathrin Endocytic Complex in Neural Stem Cells of Alzheimer's Disease Patients. Front Mol Neurosci. 2017;10:59 pubmed publisher
  131. Koistinen N, Edlund A, Menon P, Ivanova E, Bacanu S, Iverfeldt K. Nuclear localization of amyloid-? precursor protein-binding protein Fe65 is dependent on regulated intramembrane proteolysis. PLoS ONE. 2017;12:e0173888 pubmed publisher
  132. Croft C, Wade M, Kurbatskaya K, Mastrandreas P, Hughes M, Phillips E, et al. Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures. Cell Death Dis. 2017;8:e2671 pubmed publisher
  133. Klementieva O, Willén K, Martinsson I, Israelsson B, Engdahl A, Cladera J, et al. Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP. Nat Commun. 2017;8:14726 pubmed publisher
  134. Vienken H, Mabrouki N, Grabau K, Claas R, Rudowski A, Schömel N, et al. Characterization of cholesterol homeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts reveals a Niemann-Pick disease type C-like phenotype with enhanced lysosomal Ca2+ storage. Sci Rep. 2017;7:43575 pubmed publisher
  135. Gardenal E, Chiarini A, Armato U, Dal Pra I, Verkhratsky A, Rodriguez J. Increased Calcium-Sensing Receptor Immunoreactivity in the Hippocampus of a Triple Transgenic Mouse Model of Alzheimer's Disease. Front Neurosci. 2017;11:81 pubmed publisher
  136. Stachowicz A, Olszanecki R, Suski M, Głombik K, Basta Kaim A, Adamek D, et al. Proteomic Analysis of Mitochondria-Enriched Fraction Isolated from the Frontal Cortex and Hippocampus of Apolipoprotein E Knockout Mice Treated with Alda-1, an Activator of Mitochondrial Aldehyde Dehydrogenase (ALDH2). Int J Mol Sci. 2017;18: pubmed publisher
  137. Zheng T, Pu J, Chen Y, Mao Y, Guo Z, Pan H, et al. Plasma Exosomes Spread and Cluster Around ?-Amyloid Plaques in an Animal Model of Alzheimer's Disease. Front Aging Neurosci. 2017;9:12 pubmed publisher
  138. Canu N, Pagano I, La Rosa L, Pellegrino M, Ciotti M, Mercanti D, et al. Association of TrkA and APP Is Promoted by NGF and Reduced by Cell Death-Promoting Agents. Front Mol Neurosci. 2017;10:15 pubmed publisher
  139. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  140. Tao C, Hsu W, Ma Y, Cheng S, Lee E. Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against Aβ toxicity in a mouse model of Alzheimer's disease. Cell Death Differ. 2017;24:597-614 pubmed publisher
  141. Kallakuri S, Desai A, Feng K, Tummala S, Saif T, Chen C, et al. Neuronal Injury and Glial Changes Are Hallmarks of Open Field Blast Exposure in Swine Frontal Lobe. PLoS ONE. 2017;12:e0169239 pubmed publisher
  142. Mellott T, Huleatt O, Shade B, Pender S, Liu Y, Slack B, et al. Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice. PLoS ONE. 2017;12:e0170450 pubmed publisher
  143. Huang S, Mao J, Ding K, Zhou Y, Zeng X, Yang W, et al. Polysaccharides from Ganoderma lucidum Promote Cognitive Function and Neural Progenitor Proliferation in Mouse Model of Alzheimer's Disease. Stem Cell Reports. 2017;8:84-94 pubmed publisher
  144. Takahashi H, Klein Z, Bhagat S, Kaufman A, Kostylev M, Ikezu T, et al. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network. Acta Neuropathol. 2017;133:785-807 pubmed publisher
  145. Rodriguez Callejas J, Fuchs E, Perez Cruz C. Evidence of Tau Hyperphosphorylation and Dystrophic Microglia in the Common Marmoset. Front Aging Neurosci. 2016;8:315 pubmed publisher
  146. Yoshida K, Hata Y, Kinoshita K, Takashima S, Tanaka K, Nishida N. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. Acta Neuropathol. 2017;133:809-823 pubmed publisher
  147. Guillot Sestier M, Weitz T, Town T. Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease. J Vis Exp. 2016;: pubmed publisher
  148. Chen M, Wang J, Jiang J, Zheng X, Justice N, Wang K, et al. APP modulates KCC2 expression and function in hippocampal GABAergic inhibition. elife. 2017;6: pubmed publisher
  149. van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, et al. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Hum Mutat. 2017;38:297-309 pubmed publisher
  150. Park T, Ryu Y, Park H, Kim J, Go J, Noh J, et al. Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model. Int J Mol Med. 2017;39:21-30 pubmed publisher
  151. Butler C, Ogilvie K, Martinez Alsina L, Barreiro G, Beck E, Nolan C, et al. Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality. J Med Chem. 2017;60:386-402 pubmed publisher
  152. Del Turco D, Paul M, Schlaudraff J, Hick M, Endres K, Müller U, et al. Region-Specific Differences in Amyloid Precursor Protein Expression in the Mouse Hippocampus. Front Mol Neurosci. 2016;9:134 pubmed
  153. Chapuis J, Flaig A, Grenier Boley B, Eysert F, Pottiez V, Deloison G, et al. Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. Acta Neuropathol. 2017;133:955-966 pubmed publisher
  154. Kordower J, Goetz C, Chu Y, Halliday G, Nicholson D, Musial T, et al. Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient. Ann Neurol. 2017;81:46-57 pubmed publisher
  155. Shively S, Edgerton S, Iacono D, Purohit D, Qu B, Haroutunian V, et al. Localized cortical chronic traumatic encephalopathy pathology after single, severe axonal injury in human brain. Acta Neuropathol. 2017;133:353-366 pubmed publisher
  156. Zhang H, Sun S, Wu L, Pchitskaya E, Zakharova O, Fon Tacer K, et al. Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment. J Neurosci. 2016;36:11837-11850 pubmed
  157. Yang S, Lee D, Shin J, Lee S, Baek S, Kim J, et al. Nec-1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice. EMBO Mol Med. 2017;9:61-77 pubmed publisher
  158. Hu Y, Zou Y, Huang Y, Zhang Y, Lourenco G, Chen S, et al. ROCK1 Is Associated with Alzheimer's Disease-Specific Plaques, as well as Enhances Autophagosome Formation But not Autophagic A? Clearance. Front Cell Neurosci. 2016;10:253 pubmed
  159. Hübner N, Mechling A, Lee H, Reisert M, Bienert T, Hennig J, et al. The connectomics of brain demyelination: Functional and structural patterns in the cuprizone mouse model. Neuroimage. 2017;146:1-18 pubmed publisher
  160. Lejbman N, OLIVERA A, Heinzelmann M, Feng R, Yun S, Kim H, et al. Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of A?40 and lower ratios of A?42/40. Brain Inj. 2016;30:1436-1441 pubmed
  161. Noy S, Krawitz S, Del Bigio M. Chronic Traumatic Encephalopathy-Like Abnormalities in a Routine Neuropathology Service. J Neuropathol Exp Neurol. 2016;75:1145-1154 pubmed publisher
  162. Ling H, Kovacs G, Vonsattel J, DAVEY K, Mok K, Hardy J, et al. Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain. 2016;139:3237-3252 pubmed
  163. Fan Y, Wang N, Rocchi A, Zhang W, Vassar R, Zhou Y, et al. Identification of natural products with neuronal and metabolic benefits through autophagy induction. Autophagy. 2017;13:41-56 pubmed publisher
  164. Tapia Rojas C, Burgos P, Inestrosa N. Inhibition of Wnt signaling induces amyloidogenic processing of amyloid precursor protein and the production and aggregation of Amyloid-? (A?)42 peptides. J Neurochem. 2016;139:1175-1191 pubmed publisher
  165. Bangasser D, Dong H, Carroll J, Plona Z, Ding H, Rodriguez L, et al. Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer's disease-related signaling. Mol Psychiatry. 2017;22:1126-1133 pubmed publisher
  166. Woodruff G, Reyna S, Dunlap M, van der Kant R, Callender J, Young J, et al. Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations. Cell Rep. 2016;17:759-773 pubmed publisher
  167. Zuhl A, Nolan C, Brodney M, Niessen S, Atchison K, Houle C, et al. Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of ?-secretase inhibitors. Nat Commun. 2016;7:13042 pubmed publisher
  168. Auer Grumbach M, Toegel S, Schabhüttl M, Weinmann D, Chiari C, Bennett D, et al. Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies. Am J Hum Genet. 2016;99:607-623 pubmed publisher
  169. Qin X, Wang Y, Paudel H. Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of ?-Secretase 1 (BACE-1) in the Brain. J Biol Chem. 2016;291:22276-22287 pubmed
  170. Steffen J, Krohn M, Paarmann K, Schwitlick C, Brüning T, Marreiros R, et al. Revisiting rodent models: Octodon degus as Alzheimer's disease model?. Acta Neuropathol Commun. 2016;4:91 pubmed publisher
  171. Xu J, De Winter F, Farrokhi C, Rockenstein E, Mante M, Adame A, et al. Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer's disease model. Sci Rep. 2016;6:31692 pubmed publisher
  172. Manousopoulou A, Gatherer M, Smith C, Nicoll J, Woelk C, Johnson M, et al. Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2017;43:492-504 pubmed publisher
  173. Dinkins M, Enasko J, Hernandez C, Wang G, Kong J, Helwa I, et al. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse. J Neurosci. 2016;36:8653-67 pubmed publisher
  174. Badea A, Kane L, Anderson R, Qi Y, Foster M, Cofer G, et al. The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease. Neuroimage. 2016;142:498-511 pubmed publisher
  175. Manocha G, Floden A, Rausch K, Kulas J, McGregor B, Rojanathammanee L, et al. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease. J Neurosci. 2016;36:8471-86 pubmed publisher
  176. Galambos C, Minic A, Bush D, Nguyen D, Dodson B, Seedorf G, et al. Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension. PLoS ONE. 2016;11:e0159005 pubmed publisher
  177. Salta E, Sierksma A, Vanden Eynden E, De Strooper B. miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain. EMBO Mol Med. 2016;8:1005-18 pubmed publisher
  178. Kim H, Lee K, Kim A, Choi M, Choi K, Kang M, et al. A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition. Dis Model Mech. 2016;9:839-48 pubmed publisher
  179. Zhao Y, Song J, Ma X, Zhang B, Li D, Pang H. Rosiglitazone ameliorates diffuse axonal injury by reducing loss of tau and up-regulating caveolin-1 expression. Neural Regen Res. 2016;11:944-50 pubmed publisher
  180. Ayyadevara S, Balasubramaniam M, Parcon P, Barger S, Griffin W, Alla R, et al. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls. Aging Cell. 2016;15:924-39 pubmed publisher
  181. Pajares M, Jiménez Moreno N, García Yagüe A, Escoll M, De Ceballos M, Van Leuven F, et al. Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy. 2016;12:1902-1916 pubmed
  182. Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, et al. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device. Alzheimers Res Ther. 2016;8:30 pubmed publisher
  183. Bergkvist L, Sandin L, Kågedal K, Brorsson A. A?PP processing results in greater toxicity per amount of A?1-42 than individually expressed and secreted A?1-42 in Drosophila melanogaster. Biol Open. 2016;5:1030-9 pubmed publisher
  184. Li T, Braunstein K, Zhang J, Lau A, Sibener L, Deeble C, et al. The neuritic plaque facilitates pathological conversion of tau in an Alzheimer's disease mouse model. Nat Commun. 2016;7:12082 pubmed publisher
  185. Brai E, Alina Raio N, Alberi L. Notch1 hallmarks fibrillary depositions in sporadic Alzheimer's disease. Acta Neuropathol Commun. 2016;4:64 pubmed publisher
  186. Gelpi E, Hoftberger R, Graus F, Ling H, Holton J, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132:531-43 pubmed publisher
  187. Adams S, Tilton K, Kozubek J, Seshadri S, Delalle I. Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology. J Neuropathol Exp Neurol. 2016;75:779-790 pubmed
  188. Herring A, Münster Y, Akkaya T, Moghaddam S, Deinsberger K, Meyer J, et al. Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice. Alzheimers Dement. 2016;12:1273-1287 pubmed publisher
  189. Löffler T, Flunkert S, Temmel M, Hutter Paier B. Decreased Plasma A? in Hyperlipidemic APPSL Transgenic Mice Is Associated with BBB Dysfunction. Front Neurosci. 2016;10:232 pubmed publisher
  190. Marzesco A, Flötenmeyer M, Bühler A, Obermüller U, Staufenbiel M, Jucker M, et al. Highly potent intracellular membrane-associated A? seeds. Sci Rep. 2016;6:28125 pubmed publisher
  191. Shively S, Horkayne Szakaly I, Jones R, Kelly J, Armstrong R, Perl D. Characterisation of interface astroglial scarring in the human brain after blast exposure: a post-mortem case series. Lancet Neurol. 2016;15:944-953 pubmed publisher
  192. Kumar D, Choi S, Washicosky K, Eimer W, Tucker S, Ghofrani J, et al. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med. 2016;8:340ra72 pubmed publisher
  193. Bao J, Zheng L, Zhang Q, Li X, Zhang X, Li Z, et al. Deacetylation of TFEB promotes fibrillar A? degradation by upregulating lysosomal biogenesis in microglia. Protein Cell. 2016;7:417-33 pubmed publisher
  194. Chan E, Shetty M, Sajikumar S, Chen C, Soong T, Wong B. ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing Aβ impairment of insulin signaling in an Alzheimer's disease mouse model. Sci Rep. 2016;6:26119 pubmed publisher
  195. Stroh M, Winter M, Swerdlow R, McCarson K, Zhu H. Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice. Metab Brain Dis. 2016;31:951-64 pubmed publisher
  196. Beck S, Guo L, Phensy A, Tian J, Wang L, Tandon N, et al. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease. Nat Commun. 2016;7:11483 pubmed publisher
  197. Kim C, Lim E, Shin S, Krause H, Hong H. Magnetic immunoassay platform based on the planar frequency mixing magnetic technique. Biosens Bioelectron. 2016;83:293-9 pubmed publisher
  198. Jang S, Royston S, Lee G, Wang S, Chung H. Seizure-Induced Regulations of Amyloid-?, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity. Neural Plast. 2016;2016:2123748 pubmed publisher
  199. Lee K, Lee H, Lin H, Tsay H, Tsai F, Shyue S, et al. Role of transient receptor potential ankyrin 1 channels in Alzheimer's disease. J Neuroinflammation. 2016;13:92 pubmed publisher
  200. Yetman M, Fowler S, Jankowsky J. Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction. PLoS ONE. 2016;11:e0153724 pubmed publisher
  201. Kurbatskaya K, Phillips E, Croft C, Dentoni G, Hughes M, Wade M, et al. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain. Acta Neuropathol Commun. 2016;4:34 pubmed publisher
  202. Ando K, Maruko Otake A, Ohtake Y, Hayashishita M, Sekiya M, Iijima K. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity. PLoS Genet. 2016;12:e1005917 pubmed publisher
  203. Griñan Ferré C, Sarroca S, Ivanova A, Puigoriol Illamola D, Aguado F, Camins A, et al. Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice. Aging (Albany NY). 2016;8:664-84 pubmed publisher
  204. Sadleir K, Kandalepas P, Buggia Prevot V, Nicholson D, Thinakaran G, Vassar R. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease. Acta Neuropathol. 2016;132:235-56 pubmed publisher
  205. Kretner B, Trambauer J, Fukumori A, Mielke J, Kuhn P, Kremmer E, et al. Generation and deposition of Aβ43 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer's disease. EMBO Mol Med. 2016;8:458-65 pubmed publisher
  206. Son S, Cha M, Choi H, Kang S, Choi H, Lee M, et al. Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease. Autophagy. 2016;12:784-800 pubmed publisher
  207. Reinert J, Richard B, Klafki H, Friedrich B, Bayer T, Wiltfang J, et al. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models. Acta Neuropathol Commun. 2016;4:24 pubmed publisher
  208. Perez S, Sherwood C, Cranfield M, Erwin J, Mudakikwa A, Hof P, et al. Early Alzheimer's disease-type pathology in the frontal cortex of wild mountain gorillas (Gorilla beringei beringei). Neurobiol Aging. 2016;39:195-201 pubmed publisher
  209. Guillot F, Kemppainen S, Lavasseur G, Miettinen P, Laroche S, Tanila H, et al. Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2016;51:1157-73 pubmed publisher
  210. Garcia Ratés S, Morrill P, Tu H, Pottiez G, Badin A, Tormo Garcia C, et al. (I) Pharmacological profiling of a novel modulator of the α7 nicotinic receptor: Blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer brains. Neuropharmacology. 2016;105:487-499 pubmed publisher
  211. Winston C, Noël A, Neustadtl A, Parsadanian M, Barton D, Chellappa D, et al. Dendritic Spine Loss and Chronic White Matter Inflammation in a Mouse Model of Highly Repetitive Head Trauma. Am J Pathol. 2016;186:552-67 pubmed publisher
  212. Wilhelmus M, de Jager M, Smit A, van der Loo R, Drukarch B. Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models. Sci Rep. 2016;6:20569 pubmed publisher
  213. Stevenson J, Conaty E, Walsh R, Poidomani P, Samoriski C, Scollins B, et al. The Amyloid Precursor Protein of Alzheimer's Disease Clusters at the Organelle/Microtubule Interface on Organelles that Bind Microtubules in an ATP Dependent Manner. PLoS ONE. 2016;11:e0147808 pubmed publisher
  214. Peng Y, Kim M, Hullinger R, O Riordan K, Burger C, Pehar M, et al. Improved proteostasis in the secretory pathway rescues Alzheimer's disease in the mouse. Brain. 2016;139:937-52 pubmed publisher
  215. Hares K, Redondo J, Kemp K, Rice C, Scolding N, Wilkins A. Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter. Neuropathol Appl Neurobiol. 2017;43:227-241 pubmed publisher
  216. Piedrahita D, Castro Álvarez J, Boudreau R, Villegas Lanau A, Kosik K, Gallego Gómez J, et al. β-Secretase 1's Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice. Front Cell Neurosci. 2015;9:498 pubmed publisher
  217. Yuan P, Grutzendler J. Attenuation of β-Amyloid Deposition and Neurotoxicity by Chemogenetic Modulation of Neural Activity. J Neurosci. 2016;36:632-41 pubmed publisher
  218. Lian H, Litvinchuk A, Chiang A, Aithmitti N, Jankowsky J, Zheng H. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease. J Neurosci. 2016;36:577-89 pubmed publisher
  219. Chen A, Kim S, Shepardson N, Patel S, Hong S, Selkoe D. Physical and functional interaction between the α- and γ-secretases: A new model of regulated intramembrane proteolysis. J Cell Biol. 2015;211:1157-76 pubmed publisher
  220. Haas L, Salazar S, Kostylev M, Um J, Kaufman A, Strittmatter S. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease. Brain. 2016;139:526-46 pubmed publisher
  221. Lee S, Bang S, Hong Y, Lee J, Jeong H, Park S, et al. The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease. Dis Model Mech. 2016;9:295-306 pubmed publisher
  222. Müller Schiffmann A, Herring A, Abdel Hafiz L, Chepkova A, Schäble S, Wedel D, et al. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity. Brain. 2016;139:509-25 pubmed publisher
  223. Das U, Wang L, Ganguly A, Saikia J, Wagner S, Koo E, et al. Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway. Nat Neurosci. 2016;19:55-64 pubmed publisher
  224. Gyoneva S, Kim D, Katsumoto A, Kokiko Cochran O, Lamb B, Ransohoff R. Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury. J Neuroinflammation. 2015;12:228 pubmed publisher
  225. Leshchyns ka I, Liew H, Shepherd C, Halliday G, Stevens C, Ke Y, et al. Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease. Nat Commun. 2015;6:8836 pubmed publisher
  226. Tapia Rojas C, Lindsay C, Montecinos Oliva C, Arrázola M, Retamales R, Bunout D, et al. Is L-methionine a trigger factor for Alzheimer's-like neurodegeneration?: Changes in Aβ oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice. Mol Neurodegener. 2015;10:62 pubmed publisher
  227. Wang J, Lu R, Yang J, Li H, He Z, Jing N, et al. TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ production. Nat Commun. 2015;6:8876 pubmed publisher
  228. De Mario A, Castellani A, Peggion C, Massimino M, Lim D, Hill A, et al. The prion protein constitutively controls neuronal store-operated Ca(2+) entry through Fyn kinase. Front Cell Neurosci. 2015;9:416 pubmed publisher
  229. Gao L, Tian M, Zhao H, Xu Q, Huang Y, Si Q, et al. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease. J Neurochem. 2016;136:620-36 pubmed publisher
  230. Xu G, Ran Y, Fromholt S, Fu C, Yachnis A, Golde T, et al. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits. Acta Neuropathol Commun. 2015;3:72 pubmed publisher
  231. Ostapchenko V, Chen M, Guzman M, Xie Y, Lavine N, Fan J, et al. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment. J Neurosci. 2015;35:15157-69 pubmed publisher
  232. Sabogal Guáqueta A, Osorio E, Cardona Gómez G. Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice. Neuropharmacology. 2016;102:111-20 pubmed publisher
  233. Cherry J, Olschowka J, O Banion M. Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation. J Neuroinflammation. 2015;12:203 pubmed publisher
  234. Kumar R, Nordberg A, Darreh Shori T. Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs. Brain. 2016;139:174-92 pubmed publisher
  235. Quigley H, Pitha I, Welsbie D, Nguyen C, Steinhart M, Nguyen T, et al. Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma. PLoS ONE. 2015;10:e0141137 pubmed publisher
  236. Miners J, Palmer J, Love S. Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease. Brain Pathol. 2016;26:533-41 pubmed publisher
  237. Lafrenaye A, Todani M, Walker S, Povlishock J. Microglia processes associate with diffusely injured axons following mild traumatic brain injury in the micro pig. J Neuroinflammation. 2015;12:186 pubmed publisher
  238. Gabbita S, Johnson M, Kobritz N, Eslami P, Poteshkina A, Varadarajan S, et al. Oral TNFα Modulation Alters Neutrophil Infiltration, Improves Cognition and Diminishes Tau and Amyloid Pathology in the 3xTgAD Mouse Model. PLoS ONE. 2015;10:e0137305 pubmed publisher
  239. Kokiko Cochran O, Ransohoff L, Veenstra M, Lee S, Saber M, Sikora M, et al. Altered Neuroinflammation and Behavior after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease. J Neurotrauma. 2016;33:625-40 pubmed publisher
  240. Howell M, Bailey L, Cozart M, Gannon B, Gottschall P. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice. Acta Neuropathol Commun. 2015;3:54 pubmed publisher
  241. Henstridge C, Jackson R, Kim J, Herrmann A, Wright A, Harris S, et al. Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse. Acta Neuropathol Commun. 2015;3:53 pubmed publisher
  242. Keable A, Fenna K, Yuen H, Johnston D, Smyth N, Smith C, et al. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochim Biophys Acta. 2016;1862:1037-46 pubmed publisher
  243. Montine T, Monsell S, Beach T, Bigio E, Bu Y, Cairns N, et al. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease. Alzheimers Dement. 2016;12:164-169 pubmed publisher
  244. Chun Y, Oh H, Park M, Kim T, Chung S. Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C. J Neurodegener Dis. 2013;2013:407903 pubmed publisher
  245. Rolyan H, Tyurina Y, Hernandez M, Amoscato A, Sparvero L, Nmezi B, et al. Defects of Lipid Synthesis Are Linked to the Age-Dependent Demyelination Caused by Lamin B1 Overexpression. J Neurosci. 2015;35:12002-17 pubmed publisher
  246. Cavieres V, González A, Muñoz V, Yefi C, Bustamante H, Barraza R, et al. Tetrahydrohyperforin Inhibits the Proteolytic Processing of Amyloid Precursor Protein and Enhances Its Degradation by Atg5-Dependent Autophagy. PLoS ONE. 2015;10:e0136313 pubmed publisher
  247. Lundgren J, Ahmed S, Schedin Weiss S, Gouras G, Winblad B, Tjernberg L, et al. ADAM10 and BACE1 are localized to synaptic vesicles. J Neurochem. 2015;135:606-15 pubmed publisher
  248. Lee I, Jung K, Kim I, Lee H, Kim M, Yun S, et al. Human neural stem cells alleviate Alzheimer-like pathology in a mouse model. Mol Neurodegener. 2015;10:38 pubmed publisher
  249. Kovacs G, van der Zee J, Hort J, Kristoferitsch W, Leitha T, Höftberger R, et al. Clinicopathological description of two cases with SQSTM1 gene mutation associated with frontotemporal dementia. Neuropathology. 2016;36:27-38 pubmed publisher
  250. Lutzenberger M, Burwinkel M, Riemer C, Bode V, Baier M. Ablation of CCAAT/Enhancer-Binding Protein Delta (C/EBPD): Increased Plaque Burden in a Murine Alzheimer's Disease Model. PLoS ONE. 2015;10:e0134228 pubmed publisher
  251. Owais K, Huang T, Mahmood F, Hubbard J, Saraf R, Bardia A, et al. Cardiopulmonary Bypass Decreases Activation of the Signal Transducer and Activator of Transcription 3 (STAT3) Pathway in Diabetic Human Myocardium. Ann Thorac Surg. 2015;100:1636-45; discussion 1645 pubmed publisher
  252. Tousseyn T, Bajsarowicz K, Sánchez H, Gheyara A, Oehler A, Geschwind M, et al. Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes. J Neuropathol Exp Neurol. 2015;74:873-88 pubmed publisher
  253. Currinn H, Guscott B, Balklava Z, Rothnie A, Wassmer T. APP controls the formation of PI(3,5)P(2) vesicles through its binding of the PIKfyve complex. Cell Mol Life Sci. 2016;73:393-408 pubmed publisher
  254. Pogue A, Dua P, Hill J, Lukiw W. Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice. J Inorg Biochem. 2015;152:206-9 pubmed publisher
  255. McClean P, Jalewa J, Hölscher C. Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice. Behav Brain Res. 2015;293:96-106 pubmed publisher
  256. Alme M, Nystad A, Bø L, Myhr K, Vedeler C, Wergeland S, et al. Fingolimod does not enhance cerebellar remyelination in the cuprizone model. J Neuroimmunol. 2015;285:180-6 pubmed publisher
  257. Zeineh M, Chen Y, Kitzler H, Hammond R, Vogel H, Rutt B. Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease. Neurobiol Aging. 2015;36:2483-500 pubmed publisher
  258. Ziskin J, Greicius M, Zhu W, Okumu A, Adams C, Plowey E. Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia. Acta Neuropathol Commun. 2015;3:43 pubmed publisher
  259. Panmanee J, Nopparat C, Chavanich N, Shukla M, Mukda S, Song W, et al. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells. J Pineal Res. 2015;59:308-20 pubmed publisher
  260. Tan X, Xue Y, Ma T, Wang X, Li J, Lan L, et al. Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Mol Neurodegener. 2015;10:24 pubmed publisher
  261. de Jager M, Drukarch B, Hofstee M, Brevé J, Jongenelen C, Bol J, et al. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity. J Neurochem. 2015;134:1116-28 pubmed publisher
  262. Corbett G, Gonzalez F, Pahan K. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP. Proc Natl Acad Sci U S A. 2015;112:8445-50 pubmed publisher
  263. Iacono D, Geraci Erck M, Peng H, Rabin M, Kurlan R. Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses. Tremor Other Hyperkinet Mov (N Y). 2015;5: pubmed publisher
  264. Nevzglyadova O, Mikhailova E, Amen T, Zenin V, Artemov A, Kostyleva E, et al. Yeast red pigment modifies Amyloid beta growth in Alzheimer disease models in both Saccharomyces cerevisiae and Drosophila melanogaster. Amyloid. 2015;22:100-11 pubmed publisher
  265. Liu P, Reed M, Kotilinek L, Grant M, Forster C, Qiang W, et al. Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration. Cell Rep. 2015;11:1760-71 pubmed publisher
  266. Zhao Z, Sagare A, Ma Q, Halliday M, Kong P, Kisler K, et al. Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance. Nat Neurosci. 2015;18:978-87 pubmed publisher
  267. Bhatt D, Puig K, Gorr M, Wold L, Combs C. A pilot study to assess effects of long-term inhalation of airborne particulate matter on early Alzheimer-like changes in the mouse brain. PLoS ONE. 2015;10:e0127102 pubmed publisher
  268. Wang D, Kinoshita Y, Kinoshita C, Uo T, Sopher B, Cudaback E, et al. Loss of endophilin-B1 exacerbates Alzheimer's disease pathology. Brain. 2015;138:2005-19 pubmed publisher
  269. Cuddy L, Seah C, Pasternak S, Rylett R. Differential regulation of the high-affinity choline transporter by wild-type and Swedish mutant amyloid precursor protein. J Neurochem. 2015;134:769-82 pubmed publisher
  270. Rotman M, Welling M, van den Boogaard M, Moursel L, van der Graaf L, van Buchem M, et al. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake. Nucl Med Biol. 2015;42:695-702 pubmed publisher
  271. Del Mar N, von Buttlar X, Yu A, Guley N, Reiner A, Honig M. A novel closed-body model of spinal cord injury caused by high-pressure air blasts produces extensive axonal injury and motor impairments. Exp Neurol. 2015;271:53-71 pubmed publisher
  272. Plagg B, Marksteiner J, Kniewallner K, Humpel C. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease. Biogerontology. 2015;16:543-58 pubmed publisher
  273. Liu P, Paulson J, Forster C, Shapiro S, Ashe K, Zahs K. Characterization of a Novel Mouse Model of Alzheimer's Disease--Amyloid Pathology and Unique β-Amyloid Oligomer Profile. PLoS ONE. 2015;10:e0126317 pubmed publisher
  274. Reid G, Darvesh S. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model. Neuroscience. 2015;298:424-35 pubmed publisher
  275. Wang H, Sang N, Zhang C, Raghupathi R, Tanzi R, SAUNDERS A. Cathepsin L Mediates the Degradation of Novel APP C-Terminal Fragments. Biochemistry. 2015;54:2806-16 pubmed publisher
  276. La Rosa L, Perrone L, Nielsen M, Calissano P, Andersen O, Matrone C. Y682G Mutation of Amyloid Precursor Protein Promotes Endo-Lysosomal Dysfunction by Disrupting APP-SorLA Interaction. Front Cell Neurosci. 2015;9:109 pubmed publisher
  277. Webster S, Van Eldik L, Watterson D, Bachstetter A. Closed head injury in an age-related Alzheimer mouse model leads to an altered neuroinflammatory response and persistent cognitive impairment. J Neurosci. 2015;35:6554-69 pubmed publisher
  278. Hernandez Guillamon M, Mawhirt S, Blais S, Montaner J, Neubert T, Rostagno A, et al. Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9. J Biol Chem. 2015;290:15078-91 pubmed publisher
  279. Kan M, Lee J, Wilson J, Everhart A, Brown C, Hoofnagle A, et al. Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease. J Neurosci. 2015;35:5969-82 pubmed publisher
  280. Yetman M, Lillehaug S, Bjaalie J, Leergaard T, Jankowsky J. Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex. Brain Struct Funct. 2016;221:2231-49 pubmed publisher
  281. Hohsfield L, Humpel C. Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model. PLoS ONE. 2015;10:e0121930 pubmed publisher
  282. PajÄ…k B, Kania E, Orzechowski A. Nucleofection of rat pheochromocytoma PC-12 cells with human mutated beta-amyloid precursor protein gene (APP-sw) leads to reduced viability, autophagy-like process, and increased expression and secretion of beta amyloid. Biomed Res Int. 2015;2015:746092 pubmed publisher
  283. Brodney M, Beck E, Butler C, Barreiro G, Johnson E, Riddell D, et al. Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors. J Med Chem. 2015;58:3223-52 pubmed publisher
  284. Leinenga G, Götz J. Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model. Sci Transl Med. 2015;7:278ra33 pubmed publisher
  285. López González I, Schlüter A, Aso E, Garcia Esparcia P, Ansoleaga B, Llorens F, et al. Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species. J Neuropathol Exp Neurol. 2015;74:319-44 pubmed publisher
  286. Jay T, Miller C, Cheng P, Graham L, Bemiller S, Broihier M, et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med. 2015;212:287-95 pubmed publisher
  287. Reis R, Hennessy E, Murray C, Griffin Ã, Cunningham C. At the centre of neuronal, synaptic and axonal pathology in murine prion disease: degeneration of neuroanatomically linked thalamic and brainstem nuclei. Neuropathol Appl Neurobiol. 2015;41:780-97 pubmed publisher
  288. Woo J, Zhao X, Khan H, Penn C, Wang X, Joly Amado A, et al. Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Aβ ligation to β1-integrin conformers. Cell Death Differ. 2015;22:921-34 pubmed publisher
  289. Butler C, Brodney M, Beck E, Barreiro G, Nolan C, Pan F, et al. Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design. J Med Chem. 2015;58:2678-702 pubmed publisher
  290. Bennett R, Brody D. Array tomography for the detection of non-dilated, injured axons in traumatic brain injury. J Neurosci Methods. 2015;245:25-36 pubmed publisher
  291. Silverberg G, Miller M, Pascale C, Caralopoulos I, Agca Y, Agca C, et al. Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP. Fluids Barriers CNS. 2015;12:2 pubmed publisher
  292. Jensen M, Arvaniti M, Mikkelsen J, Michalski D, Pinborg L, Härtig W, et al. Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease. Neurobiol Aging. 2015;36:1629-1638 pubmed publisher
  293. Vallortigara J, Rangarajan S, Whitfield D, Alghamdi A, Howlett D, Hortobágyi T, et al. Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. F1000Res. 2014;3:108 pubmed publisher
  294. Sabogal Guáqueta A, Muñoz Manco J, Ramírez Pineda J, Lamprea Rodriguez M, Osorio E, Cardona Gómez G. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice. Neuropharmacology. 2015;93:134-45 pubmed publisher
  295. Porquet D, Andrés Benito P, Griñán Ferré C, Camins A, Ferrer I, Canudas A, et al. Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8). Age (Dordr). 2015;37:9747 pubmed publisher
  296. Wu Z, Yang B, Liu C, Liang G, Eckenhoff M, Liu W, et al. Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice. Alzheimer Dis Assoc Disord. 2015;29:184-191 pubmed publisher
  297. Chang J, Lee M, Lin S, Yang L, Sun H, Sze C, et al. Trafficking protein particle complex 6A delta (TRAPPC6AΔ) is an extracellular plaque-forming protein in the brain. Oncotarget. 2015;6:3578-89 pubmed
  298. Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R, et al. TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol. 2015;129:429-47 pubmed publisher
  299. Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques. Nat Commun. 2015;6:6176 pubmed publisher
  300. Yang Y, Shepherd C, Halliday G. Aneuploidy in Lewy body diseases. Neurobiol Aging. 2015;36:1253-60 pubmed publisher
  301. Maurya S, Mishra J, Abbas S, Bandyopadhyay S. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators. Mol Neurobiol. 2016;53:968-82 pubmed publisher
  302. Postupna N, Keene C, Crane P, Gonzalez Cuyar L, Sonnen J, Hewitt J, et al. Cerebral cortical Aβ42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE. J Neuropathol Exp Neurol. 2015;74:100-9 pubmed publisher
  303. Sadleir K, Eimer W, Cole S, Vassar R. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Mol Neurodegener. 2015;10:1 pubmed publisher
  304. Kang E, Cho J. Effects of treadmill exercise on brain insulin signaling and β-amyloid in intracerebroventricular streptozotocin induced-memory impairment in rats. J Exerc Nutrition Biochem. 2014;18:89-96 pubmed publisher
  305. Ashby E, Miners J, Kumar S, Walter J, Love S, Kehoe P. Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia. Neuropathol Appl Neurobiol. 2015;41:428-44 pubmed publisher
  306. HÃ¥nell A, Greer J, McGinn M, Povlishock J. Traumatic brain injury-induced axonal phenotypes react differently to treatment. Acta Neuropathol. 2015;129:317-32 pubmed publisher
  307. Kawa L, Arborelius U, Yoshitake T, Kehr J, Hökfelt T, Risling M, et al. Neurotransmitter Systems in a Mild Blast Traumatic Brain Injury Model: Catecholamines and Serotonin. J Neurotrauma. 2015;32:1190-9 pubmed publisher
  308. Meng P, Yoshida H, Tanji K, Matsumiya T, Xing F, Hayakari R, et al. Carnosic acid attenuates apoptosis induced by amyloid-β 1-42 or 1-43 in SH-SY5Y human neuroblastoma cells. Neurosci Res. 2015;94:1-9 pubmed publisher
  309. Shukla M, Htoo H, Wintachai P, Hernandez J, Dubois C, Postina R, et al. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17. J Pineal Res. 2015;58:151-65 pubmed publisher
  310. Hohsfield L, Daschil N, Orädd G, Strömberg I, Humpel C. Vascular pathology of 20-month-old hypercholesterolemia mice in comparison to triple-transgenic and APPSwDI Alzheimer's disease mouse models. Mol Cell Neurosci. 2014;63:83-95 pubmed
  311. Fine J, Renner D, Forsberg A, Cameron R, Galick B, Le C, et al. Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. Neurosci Lett. 2015;584:362-7 pubmed publisher
  312. Vingtdeux V, Tanis J, Chandakkar P, Zhao H, Dreses Werringloer U, Campagne F, et al. Effect of the CALHM1 G330D and R154H human variants on the control of cytosolic Ca2+ and Aβ levels. PLoS ONE. 2014;9:e112484 pubmed publisher
  313. Deng X, Li M, Ai W, He L, Lu D, Patrylo P, et al. Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats. Adv Alzheimer Dis. 2014;3:78-93 pubmed
  314. Thomzig A, Wagenführ K, Daus M, Joncic M, Schulz Schaeffer W, Thanheiser M, et al. Decontamination of medical devices from pathological amyloid-?-, tau- and ?-synuclein aggregates. Acta Neuropathol Commun. 2014;2:151 pubmed publisher
  315. Joshi G, Gan K, Johnson D, Johnson J. Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy. Neurobiol Aging. 2015;36:664-79 pubmed publisher
  316. Forny Germano L, Lyra e Silva N, Batista A, Brito Moreira J, Gralle M, Boehnke S, et al. Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman primates. J Neurosci. 2014;34:13629-43 pubmed publisher
  317. Maloney J, Bainbridge T, Gustafson A, Zhang S, Kyauk R, Steiner P, et al. Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein. J Biol Chem. 2014;289:30990-1000 pubmed publisher
  318. Lee S, Xu G, Jay T, Bhatta S, Kim K, Jung S, et al. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway. J Neurosci. 2014;34:12538-46 pubmed publisher
  319. Lue L, Schmitz C, Serrano G, Sue L, Beach T, Walker D. TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices. Brain Pathol. 2015;25:469-80 pubmed publisher
  320. Maarouf C, Kokjohn T, Walker D, Whiteside C, Kalback W, Whetzel A, et al. Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease. PLoS ONE. 2014;9:e105784 pubmed publisher
  321. de la Escosura Muñiz A, Plichta Z, Horák D, Merkoçi A. Alzheimer's disease biomarkers detection in human samples by efficient capturing through porous magnetic microspheres and labelling with electrocatalytic gold nanoparticles. Biosens Bioelectron. 2015;67:162-9 pubmed publisher
  322. Yan Y, Eipper B, Mains R. Kalirin-9 and Kalirin-12 Play Essential Roles in Dendritic Outgrowth and Branching. Cereb Cortex. 2015;25:3487-501 pubmed publisher
  323. Dunn H, Ager R, Baglietto Vargas D, Cheng D, Kitazawa M, Cribbs D, et al. Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model. J Alzheimers Dis. 2015;43:893-903 pubmed publisher
  324. Hanenberg M, McAfoose J, Kulic L, Welt T, Wirth F, Parizek P, et al. Amyloid-β peptide-specific DARPins as a novel class of potential therapeutics for Alzheimer disease. J Biol Chem. 2014;289:27080-9 pubmed publisher
  325. Yarchoan M, Toledo J, Lee E, Arvanitakis Z, Kazi H, Han L, et al. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathol. 2014;128:679-89 pubmed publisher
  326. Whitfield D, Vallortigara J, Alghamdi A, Howlett D, Hortobagyi T, Johnson M, et al. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment. Neurobiol Aging. 2014;35:2836-2844 pubmed publisher
  327. Toyn J, Thompson L, Lentz K, Meredith J, Burton C, Sankaranararyanan S, et al. Identification and Preclinical Pharmacology of the ?-Secretase Modulator BMS-869780. Int J Alzheimers Dis. 2014;2014:431858 pubmed publisher
  328. Kohler C, Dinekov M, Götz J. Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and A? amyloidosis. Neurobiol Dis. 2014;71:169-79 pubmed publisher
  329. Zhou Y, Hayashi I, Wong J, Tugusheva K, Renger J, Zerbinatti C. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease. PLoS ONE. 2014;9:e103187 pubmed publisher
  330. Zeldich E, Chen C, Colvin T, Bove Fenderson E, Liang J, Tucker Zhou T, et al. The neuroprotective effect of Klotho is mediated via regulation of members of the redox system. J Biol Chem. 2014;289:24700-15 pubmed publisher
  331. Sadleir K, Eimer W, Kaufman R, Osten P, Vassar R. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease. PLoS ONE. 2014;9:e101643 pubmed publisher
  332. Mantile F, Trovato M, Santoni A, Barba P, Ottonello S, De Berardinis P, et al. Alum and squalene-oil-in-water emulsion enhance the titer and avidity of anti-A? antibodies induced by multimeric protein antigen (1-11)E2, preserving the Igg1-skewed isotype distribution. PLoS ONE. 2014;9:e101474 pubmed publisher
  333. Wu Z, Guo Z, Gearing M, Chen G. Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's [corrected] disease model. Nat Commun. 2014;5:4159 pubmed publisher
  334. Fowler S, Chiang A, Savjani R, Larson M, Sherman M, Schuler D, et al. Genetic modulation of soluble A? rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease. J Neurosci. 2014;34:7871-85 pubmed publisher
  335. Pedr s I, Petrov D, Allgaier M, Sureda F, Barroso E, Beas Zarate C, et al. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. Biochim Biophys Acta. 2014;1842:1556-66 pubmed publisher
  336. Cameron R, Quinn S, Cairns L, MacLeod R, Samuel I, Smith B, et al. The phosphorylation of Hsp20 enhances its association with amyloid-? to increase protection against neuronal cell death. Mol Cell Neurosci. 2014;61:46-55 pubmed publisher
  337. Durk M, Han K, Chow E, Ahrens R, Henderson J, Fraser P, et al. 1?,25-Dihydroxyvitamin D3 reduces cerebral amyloid-? accumulation and improves cognition in mouse models of Alzheimer's disease. J Neurosci. 2014;34:7091-101 pubmed publisher
  338. Shilling D, Müller M, Takano H, Mak D, Abel T, Coulter D, et al. Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis. J Neurosci. 2014;34:6910-23 pubmed publisher
  339. Fu Y, Rusznák Z, Kwok J, Kim W, Paxinos G. Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hA?PPSwInd-J20 mouse. J Alzheimers Dis. 2014;41:1177-92 pubmed publisher
  340. Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S, Zaheer A. Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain. J Alzheimers Dis. 2014;40:297-308 pubmed publisher
  341. Coppieters N, Dieriks B, Lill C, Faull R, Curtis M, Dragunow M. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Neurobiol Aging. 2014;35:1334-44 pubmed publisher
  342. Ridwan S, Bauer H, Frauenknecht K, Hefti K, von Pein H, Sommer C. Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease. J Anat. 2014;224:377-91 pubmed publisher
  343. Moore S, Khalaj A, Yoon J, Patel R, Hannsun G, Yoo T, et al. Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis. Brain Behav. 2013;3:664-82 pubmed publisher
  344. Bana L, Minniti S, Salvati E, Sesana S, Zambelli V, Cagnotto A, et al. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect A? aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease. Nanomedicine. 2014;10:1583-90 pubmed publisher
  345. Medeiros R, Castello N, Cheng D, Kitazawa M, Baglietto Vargas D, Green K, et al. ?7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles. Am J Pathol. 2014;184:520-9 pubmed publisher
  346. El Ami T, Moll L, Carvalhal Marques F, Volovik Y, Reuveni H, Cohen E. A novel inhibitor of the insulin/IGF signaling pathway protects from age-onset, neurodegeneration-linked proteotoxicity. Aging Cell. 2014;13:165-74 pubmed publisher
  347. ElAli A, Theriault P, Prefontaine P, Rivest S. Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation. Acta Neuropathol Commun. 2013;1:75 pubmed publisher
  348. Marchese M, Cowan D, Head E, Ma D, Karimi K, Ashthorpe V, et al. Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease. J Alzheimers Dis. 2014;39:191-210 pubmed publisher
  349. Bhaskar K, Maphis N, Xu G, Varvel N, Kokiko Cochran O, Weick J, et al. Microglial derived tumor necrosis factor-? drives Alzheimer's disease-related neuronal cell cycle events. Neurobiol Dis. 2014;62:273-85 pubmed publisher
  350. Kelly K, Beck S, Metcalf Pate K, Queen S, Dorsey J, Adams R, et al. Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain. AIDS. 2013;27:F21-8 pubmed publisher
  351. Washington P, Morffy N, Parsadanian M, Zapple D, Burns M. Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model. J Neurotrauma. 2014;31:125-34 pubmed publisher
  352. Li W, Tang Y, Fan Z, Meng Y, Yang G, Luo J, et al. Autophagy is involved in oligodendroglial precursor-mediated clearance of amyloid peptide. Mol Neurodegener. 2013;8:27 pubmed publisher
  353. Sadleir K, Bennett D, Schneider J, Vassar R. Elevated A?42 in aged, non-demented individuals with cerebral atherosclerosis. Curr Alzheimer Res. 2013;10:785-9 pubmed
  354. Kang E, Kwon I, Koo J, Kim E, Kim C, Lee J, et al. Treadmill exercise represses neuronal cell death and inflammation during A?-induced ER stress by regulating unfolded protein response in aged presenilin 2 mutant mice. Apoptosis. 2013;18:1332-1347 pubmed publisher
  355. Devi L, Ohno M. Mechanisms that lessen benefits of ?-secretase reduction in a mouse model of Alzheimer's disease. Transl Psychiatry. 2013;3:e284 pubmed publisher
  356. Jackson K, Barisone G, Diaz E, Jin L, DeCarli C, Despa F. Amylin deposition in the brain: A second amyloid in Alzheimer disease?. Ann Neurol. 2013;74:517-26 pubmed publisher
  357. Kang M, Baek S, Chun Y, Moore A, Landman N, Berman D, et al. Modulation of lipid kinase PI4KII? activity and lipid raft association of presenilin 1 underlies ?-secretase inhibition by ginsenoside (20S)-Rg3. J Biol Chem. 2013;288:20868-82 pubmed publisher
  358. Lim D, Iyer A, Ronco V, Grolla A, Canonico P, Aronica E, et al. Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB. Glia. 2013;61:1134-45 pubmed publisher
  359. Brana C, Frossard M, Pescini Gobert R, Martinier N, Boschert U, Seabrook T. Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions. Neuropathol Appl Neurobiol. 2014;40:564-78 pubmed publisher
  360. Hebron M, Algarzae N, Lonskaya I, Moussa C. Fractalkine signaling and Tau hyper-phosphorylation are associated with autophagic alterations in lentiviral Tau and A?1-42 gene transfer models. Exp Neurol. 2014;251:127-38 pubmed publisher
  361. Choi J, Kaur G, Mazzella M, Morales Corraliza J, Levy E, Mathews P. Early endosomal abnormalities and cholinergic neuron degeneration in amyloid-? protein precursor transgenic mice. J Alzheimers Dis. 2013;34:691-700 pubmed publisher
  362. Zheng L, Cedazo Minguez A, Hallbeck M, Jerhammar F, Marcusson J, Terman A. Intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system. Transl Neurodegener. 2012;1:19 pubmed publisher
  363. Saito Y, Inoue T, Zhu G, Kimura N, Okada M, Nishimura M, et al. Hyperpolarization-activated cyclic nucleotide gated channels: a potential molecular link between epileptic seizures and A? generation in Alzheimer's disease. Mol Neurodegener. 2012;7:50 pubmed publisher
  364. Bachstetter A, Norris C, Sompol P, Wilcock D, Goulding D, Neltner J, et al. Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology. J Neurosci. 2012;32:10201-10 pubmed publisher
  365. Zheng Y, Wang Q, Xiao B, Lu Q, Wang Y, Wang X. Involvement of receptor tyrosine kinase Tyro3 in amyloidogenic APP processing and ?-amyloid deposition in Alzheimer's disease models. PLoS ONE. 2012;7:e39035 pubmed publisher
  366. Killian R, Flippin J, Herrera C, Almenar Queralt A, Goldstein L. Kinesin light chain 1 suppression impairs human embryonic stem cell neural differentiation and amyloid precursor protein metabolism. PLoS ONE. 2012;7:e29755 pubmed publisher
  367. Zetterberg H, Mörtberg E, Song L, Chang L, Provuncher G, Patel P, et al. Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid ? levels in humans. PLoS ONE. 2011;6:e28263 pubmed publisher
  368. Huizinga R, van der Star B, Kipp M, Jong R, Gerritsen W, Clarner T, et al. Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis. Glia. 2012;60:422-31 pubmed publisher
  369. Zheng L, Terman A, Hallbeck M, Dehvari N, Cowburn R, Benedikz E, et al. Macroautophagy-generated increase of lysosomal amyloid β-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells. Autophagy. 2011;7:1528-45 pubmed
  370. Chapuis J, Vingtdeux V, Capiralla H, Davies P, Marambaud P. Gas1 interferes with A?PP trafficking by facilitating the accumulation of immature A?PP in endoplasmic reticulum-associated raft subdomains. J Alzheimers Dis. 2012;28:127-35 pubmed publisher
  371. Ranganathan S, Noyes N, Migliorini M, Winkles J, Battey F, Hyman B, et al. LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein trafficking. J Neurosci. 2011;31:10836-46 pubmed publisher
  372. Chapuis J, Vingtdeux V, Campagne F, Davies P, Marambaud P. Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein. Hum Mol Genet. 2011;20:2026-36 pubmed publisher
  373. Beyer A, von Einem B, Schwanzar D, Keller I, Hellrung A, Thal D, et al. Engulfment adapter PTB domain containing 1 interacts with and affects processing of the amyloid-? precursor protein. Neurobiol Aging. 2012;33:732-43 pubmed publisher
  374. van Noort J, Bsibsi M, Gerritsen W, van der Valk P, Bajramovic J, Steinman L, et al. Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol. 2010;69:694-703 pubmed publisher
  375. Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon J, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem. 2010;285:9100-13 pubmed publisher
  376. Portelius E, Brinkmalm G, Tran A, Andreasson U, Zetterberg H, Westman Brinkmalm A, et al. Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid. Exp Neurol. 2010;223:351-8 pubmed publisher
  377. Herring A, Ambrée O, Tomm M, Habermann H, Sachser N, Paulus W, et al. Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology. Exp Neurol. 2009;216:184-92 pubmed publisher
  378. Mankowski J, Queen S, Fernandez C, Tarwater P, Karper J, Adams R, et al. Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaques. PLoS ONE. 2008;3:e3603 pubmed publisher
  379. Moeller J, Macaulay R, Valdmanis P, Weston L, Rouleau G, Dupre N. Autosomal dominant sensory ataxia: a neuroaxonal dystrophy. Acta Neuropathol. 2008;116:331-6 pubmed publisher
  380. Ryoo S, Cho H, Lee H, Jeong H, Radnaabazar C, Kim Y, et al. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. J Neurochem. 2008;104:1333-44 pubmed
  381. Ai J, Liu E, Wang J, Chen Y, Yu J, Baker A. Calpain inhibitor MDL-28170 reduces the functional and structural deterioration of corpus callosum following fluid percussion injury. J Neurotrauma. 2007;24:960-78 pubmed
  382. Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch M, et al. Expression of APP pathway mRNAs and proteins in Alzheimer's disease. Brain Res. 2007;1161:116-23 pubmed
  383. Nizzari M, Venezia V, Repetto E, Caorsi V, Magrassi R, Gagliani M, et al. Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling. J Biol Chem. 2007;282:13833-44 pubmed
  384. German A, Myint K, Mai N, Pomeroy I, Phu N, Tzartos J, et al. A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg. 2006;100:1135-45 pubmed
  385. Kirazov L, Kirazovi E, Schliebs R. L-glutamate and phorbol ester stimulate the release of secretory amyloid precursor protein from rat cortical synaptosomes. Acta Biol Hung. 2005;56:177-83 pubmed
  386. Helke K, Queen S, Tarwater P, Turchan Cholewo J, Nath A, Zink M, et al. 14-3-3 protein in CSF: an early predictor of SIV CNS disease. J Neuropathol Exp Neurol. 2005;64:202-8 pubmed
  387. Sasaki K, Doh ura K, Wakisaka Y, Tomoda H, Iwaki T. Fatal familial insomnia with an unusual prion protein deposition pattern: an autopsy report with an experimental transmission study. Neuropathol Appl Neurobiol. 2005;31:80-7 pubmed
  388. Chauhan N, Siegel G. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease. Expert Rev Vaccines. 2004;3:717-25 pubmed
  389. Lee K, Lee S, Kim H, Song J, Yang S, Paik S, et al. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. J Neurosci Res. 2004;76:572-80 pubmed
  390. Trysberg E, Höglund K, Svenungsson E, Blennow K, Tarkowski A. Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Res Ther. 2004;6:R129-36 pubmed
  391. Richardson J, Kendal C, Anderson R, Priest F, Gower E, Soden P, et al. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience. 2003;122:213-28 pubmed
  392. Anderson R, Brown C, Blumbergs P, McLean A, Jones N. Impact mechanics and axonal injury in a sheep model. J Neurotrauma. 2003;20:961-74 pubmed
  393. Araki Y, Tomita S, Yamaguchi H, Miyagi N, Sumioka A, Kirino Y, et al. Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta-protein precursor metabolism. J Biol Chem. 2003;278:49448-58 pubmed
  394. Weed M, Hienz R, Brady J, Adams R, Mankowski J, Clements J, et al. Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection. J Neurovirol. 2003;9:452-64 pubmed
  395. King G, Perez R, Steinhilb M, Gaut J, Turner R. X11alpha modulates secretory and endocytic trafficking and metabolism of amyloid precursor protein: mutational analysis of the YENPTY sequence. Neuroscience. 2003;120:143-54 pubmed
  396. Stone J, Okonkwo D, Singleton R, Mutlu L, Helm G, Povlishock J. Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid Beta peptide in traumatic axonal injury. J Neurotrauma. 2002;19:601-14 pubmed
  397. Mankowski J, Queen S, Tarwater P, Fox K, Perry V. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol. 2002;61:85-90 pubmed
  398. Daugherty B, Green S. Endosomal sorting of amyloid precursor protein-P-selectin chimeras influences secretase processing. Traffic. 2001;2:908-16 pubmed
  399. Wong A, Lüth H, Deuther Conrad W, Dukic Stefanovic S, Gasic Milenkovic J, Arendt T, et al. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res. 2001;920:32-40 pubmed
  400. Steinhilb M, Turner R, Gaut J. The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by beta-Secretase. J Biol Chem. 2001;276:4476-84 pubmed
  401. Lefterov I, Koldamova R, Lazo J. Human bleomycin hydrolase regulates the secretion of amyloid precursor protein. FASEB J. 2000;14:1837-47 pubmed
  402. Tomita S, Ozaki T, Taru H, Oguchi S, Takeda S, Yagi Y, et al. Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein. J Biol Chem. 1999;274:2243-54 pubmed
  403. Huang Y, Herman M, Liu J, Katsetos C, Wills M, Savory J. Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates. Brain Res. 1997;771:213-20 pubmed
  404. Solomon B, Koppel R, Hanan E, Katzav T. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Proc Natl Acad Sci U S A. 1996;93:452-5 pubmed
  405. Sherriff F, Bridges L, Gentleman S, Sivaloganathan S, Wilson S. Markers of axonal injury in post mortem human brain. Acta Neuropathol. 1994;88:433-9 pubmed
  406. Webster M, Groome N, Francis P, Pearce B, Sherriff F, Thinakaran G, et al. A novel protein, amyloid precursor-like protein 2, is present in human brain, cerebrospinal fluid and conditioned media. Biochem J. 1995;310 ( Pt 1):95-9 pubmed